| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3 iron, 4 sulfur cluster binding | 2.07e-04 | 3 | 167 | 2 | GO:0051538 | |
| GeneOntologyMolecularFunction | 5-methylcytosine dioxygenase activity | 2.07e-04 | 3 | 167 | 2 | GO:0070579 | |
| GeneOntologyMolecularFunction | aconitate hydratase activity | 2.07e-04 | 3 | 167 | 2 | GO:0003994 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.01e-04 | 70 | 167 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 3.58e-04 | 17 | 167 | 3 | GO:0008574 | |
| GeneOntologyMolecularFunction | histone binding | 4.03e-04 | 265 | 167 | 9 | GO:0042393 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 4.13e-04 | 4 | 167 | 2 | GO:0030197 | |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB6 ARHGAP32 KALRN SZT2 LAMA1 LAMB2 CRPPA ALS2 RUNX3 EDN2 GSK3B CDKL5 ABLIM1 BCL11B OTX2 PTPRM PTPRZ1 COBL | 9.89e-07 | 566 | 169 | 18 | GO:0007409 |
| GeneOntologyBiologicalProcess | axon development | EPHB6 ARHGAP32 KALRN SZT2 LAMA1 LAMB2 CRPPA ALS2 RUNX3 EDN2 GSK3B CDKL5 JUN ABLIM1 BCL11B OTX2 PTPRM PTPRZ1 COBL | 1.42e-06 | 642 | 169 | 19 | GO:0061564 |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB6 ARHGAP32 FAT4 KALRN SZT2 LAMA1 MPDZ LAMB2 CRPPA ALS2 RUNX3 PRAG1 EDN2 GSK3B CDKL5 FBXO38 JUN ABLIM1 BCL11B OTX2 MRTFB PTPRM PTPRZ1 CBFA2T2 FSHR COBL RIMS2 OTOG | 1.93e-06 | 1285 | 169 | 28 | GO:0031175 |
| GeneOntologyBiologicalProcess | chromatin organization | TET2 EP400 CHAF1A BCL7B HIPK2 DAXX RIOX1 CHD8 UBN2 GSK3B YEATS2 KMT2C BRD2 BRCA1 ARID2 FSHR NFRKB SYCP1 KMT2A BICRAL ATM TET3 | 4.30e-06 | 896 | 169 | 22 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TET2 EP400 CHAF1A BCL7B HIPK2 DAXX RIOX1 CHD8 POGZ UBN2 GSK3B YEATS2 KMT2C BRD2 BRCA1 ARID2 FSHR NFRKB SYCP1 KMT2A BICRAL ATM TET3 | 7.36e-06 | 999 | 169 | 23 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | TET2 EP400 CHAF1A BCL7B HIPK2 DAXX RIOX1 CHD8 GSK3B YEATS2 KMT2C BRD2 BRCA1 ARID2 NFRKB KMT2A BICRAL ATM TET3 | 1.12e-05 | 741 | 169 | 19 | GO:0006338 |
| GeneOntologyBiologicalProcess | post-embryonic development | 1.58e-05 | 135 | 169 | 8 | GO:0009791 | |
| GeneOntologyBiologicalProcess | regulation of cell-matrix adhesion | 2.16e-05 | 141 | 169 | 8 | GO:0001952 | |
| GeneOntologyBiologicalProcess | neuron development | EPHB6 ARHGAP32 FAT4 KALRN SZT2 LAMA1 MPDZ LAMB2 CRPPA ALS2 RUNX3 PRAG1 EDN2 GSK3B CDKL5 FBXO38 JUN ABLIM1 BCL11B OTX2 MRTFB PTPRM PTPRZ1 CBFA2T2 FSHR COBL RIMS2 OTOG | 2.20e-05 | 1463 | 169 | 28 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB6 ARHGAP32 KALRN SZT2 LAMA1 LAMB2 CRPPA ALS2 RUNX3 EDN2 GSK3B CDKL5 ABLIM1 BCL11B OTX2 PTPRM PTPRZ1 COBL RIMS2 | 3.32e-05 | 802 | 169 | 19 | GO:0048812 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB6 ARHGAP32 KALRN SZT2 LAMA1 LAMB2 CRPPA ALS2 RUNX3 PRAG1 BRWD3 EDN2 GSK3B SHROOM4 CDKL5 ABLIM1 BCL11B OTX2 PTPRM PTPRZ1 IGHM PKHD1 COBL RIMS2 | 4.23e-05 | 1194 | 169 | 24 | GO:0000902 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB6 ARHGAP32 KALRN SZT2 LAMA1 LAMB2 CRPPA ALS2 RUNX3 EDN2 GSK3B CDKL5 ABLIM1 BCL11B OTX2 PTPRM PTPRZ1 COBL RIMS2 | 4.41e-05 | 819 | 169 | 19 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB6 ARHGAP32 KALRN SZT2 LAMA1 LAMB2 CRPPA ALS2 RUNX3 EDN2 GSK3B CDKL5 ABLIM1 BCL11B OTX2 PTPRM PTPRZ1 COBL | 4.43e-05 | 748 | 169 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB6 ARHGAP32 KALRN SZT2 LAMA1 LAMB2 CRPPA ALS2 RUNX3 EDN2 GSK3B CDKL5 ABLIM1 BCL11B OTX2 PTPRM PTPRZ1 COBL RIMS2 | 4.94e-05 | 826 | 169 | 19 | GO:0048858 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TET2 CRTC3 HIVEP1 HIPK2 DAXX CHD8 POGZ MLLT10 DCN GSK3B ZIC1 HINFP KMT2C JUN ABLIM1 BCL11B OTX2 MRTFB BRCA1 ARID2 ZMIZ2 KMT2A ASXL2 ATM TET3 TBX5 | 6.57e-05 | 1390 | 169 | 26 | GO:0045944 |
| GeneOntologyBiologicalProcess | locomotory behavior | 1.22e-04 | 284 | 169 | 10 | GO:0007626 | |
| GeneOntologyBiologicalProcess | axon guidance | EPHB6 KALRN LAMA1 LAMB2 CRPPA RUNX3 ABLIM1 BCL11B OTX2 PTPRM | 1.26e-04 | 285 | 169 | 10 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | EPHB6 KALRN LAMA1 LAMB2 CRPPA RUNX3 ABLIM1 BCL11B OTX2 PTPRM | 1.29e-04 | 286 | 169 | 10 | GO:0097485 |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.84e-04 | 14 | 169 | 3 | GO:2001046 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 2.55e-04 | 254 | 169 | 9 | GO:0010810 | |
| GeneOntologyBiologicalProcess | DNA repair | EP400 ZGRF1 CHAF1A BCL7B POGZ JMY CEP164 HINFP BRCA1 ARID2 NFRKB SYCP1 MARF1 BOD1L1 ATM | 2.97e-04 | 648 | 169 | 15 | GO:0006281 |
| GeneOntologyBiologicalProcess | behavior | CACNA1B AFF2 KALRN HIPK2 ALS2 CHD8 GRIK1 GRIK2 ZIC1 JUN SLC18A2 PTPRZ1 SCN1A FSHR KMT2A MRGPRX2 PUM1 OTOG | 3.88e-04 | 891 | 169 | 18 | GO:0007610 |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 3.91e-04 | 116 | 169 | 6 | GO:0008344 | |
| GeneOntologyBiologicalProcess | pre-B cell allelic exclusion | 3.96e-04 | 4 | 169 | 2 | GO:0002331 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 3.99e-04 | 270 | 169 | 9 | GO:0007160 | |
| GeneOntologyCellularComponent | postsynaptic density | ARHGAP32 KALRN SPTBN1 ANKS1B MPDZ ALS2 GRIK1 GRIK2 CSMD2 GSK3B CDKL5 ABLIM1 PTPRZ1 | 1.02e-04 | 451 | 173 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.05e-04 | 30 | 173 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.48e-04 | 96 | 173 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | asymmetric synapse | ARHGAP32 KALRN SPTBN1 ANKS1B MPDZ ALS2 GRIK1 GRIK2 CSMD2 GSK3B CDKL5 ABLIM1 PTPRZ1 | 1.77e-04 | 477 | 173 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | laminin-3 complex | 2.03e-04 | 3 | 173 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | postsynaptic specialization | ARHGAP32 KALRN SPTBN1 ANKS1B MPDZ ALS2 GRIK1 GRIK2 CSMD2 GSK3B CDKL5 ABLIM1 PTPRZ1 | 2.96e-04 | 503 | 173 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | neuron to neuron synapse | ARHGAP32 KALRN SPTBN1 ANKS1B MPDZ ALS2 GRIK1 GRIK2 CSMD2 GSK3B CDKL5 ABLIM1 PTPRZ1 | 4.29e-04 | 523 | 173 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | ATPase complex | 7.24e-04 | 129 | 173 | 6 | GO:1904949 | |
| GeneOntologyCellularComponent | XY body | 8.73e-04 | 23 | 173 | 3 | GO:0001741 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 9.99e-04 | 6 | 173 | 2 | GO:0032983 | |
| HumanPheno | Steroetypic upper-extremity movements | 2.91e-06 | 57 | 58 | 7 | HP:5200018 | |
| MousePheno | abnormal learning/memory/conditioning | CACNA1B ARHGAP32 AFF2 KALRN NEXMIF ZGRF1 DYTN KIF1B ZNF280C LAMA1 HIPK2 KIAA1549 KIF4A ALS2 CHD8 GRIK2 POGZ UBN2 GSK3B C2CD2L CDKL5 TULP4 SLC18A2 PTPRZ1 SCN1A ZMIZ2 MRGPRX2 KIF4B ATM | 1.20e-05 | 1239 | 140 | 29 | MP:0002063 |
| MousePheno | abnormal cognition | CACNA1B ARHGAP32 AFF2 KALRN NEXMIF ZGRF1 DYTN KIF1B ZNF280C LAMA1 HIPK2 KIAA1549 KIF4A ALS2 CHD8 GRIK2 POGZ UBN2 GSK3B C2CD2L CDKL5 TULP4 SLC18A2 PTPRZ1 SCN1A ZMIZ2 MRGPRX2 KIF4B ATM | 1.33e-05 | 1246 | 140 | 29 | MP:0014114 |
| MousePheno | abnormal associative learning | CACNA1B AFF2 KALRN NEXMIF KIF4A GRIK2 POGZ GSK3B CDKL5 TULP4 SLC18A2 PTPRZ1 SCN1A KIF4B | 3.99e-05 | 393 | 140 | 14 | MP:0002062 |
| MousePheno | abnormal contextual conditioning behavior | KALRN NEXMIF KIF4A GRIK2 POGZ GSK3B CDKL5 PTPRZ1 SCN1A KIF4B | 4.05e-05 | 205 | 140 | 10 | MP:0001469 |
| MousePheno | abnormal behavioral response to xenobiotic | CACNA1B ARHGAP32 SZT2 ANKS1B HIPK2 MPDZ KIF4A GRIK2 JUN SLC18A2 SCN1A KIF4B | 6.42e-05 | 309 | 140 | 12 | MP:0009745 |
| MousePheno | myometrium hypoplasia | 9.96e-05 | 2 | 140 | 2 | MP:0009090 | |
| MousePheno | abnormal response to novel odor | 1.12e-04 | 10 | 140 | 3 | MP:0003462 | |
| Domain | Kinesin_motor_CS | 3.48e-05 | 41 | 171 | 5 | IPR019821 | |
| Domain | Kinesin-like_fam | 4.41e-05 | 43 | 171 | 5 | IPR027640 | |
| Domain | - | 4.94e-05 | 44 | 171 | 5 | 3.40.850.10 | |
| Domain | Kinesin | 4.94e-05 | 44 | 171 | 5 | PF00225 | |
| Domain | KISc | 4.94e-05 | 44 | 171 | 5 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 4.94e-05 | 44 | 171 | 5 | PS00411 | |
| Domain | Kinesin_motor_dom | 4.94e-05 | 44 | 171 | 5 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 4.94e-05 | 44 | 171 | 5 | PS50067 | |
| Domain | DUF3827 | 8.33e-05 | 2 | 171 | 2 | PF12877 | |
| Domain | DUF3827 | 8.33e-05 | 2 | 171 | 2 | IPR024606 | |
| Domain | AconitaseA/IPMdHydase_ssu_swvl | 2.49e-04 | 3 | 171 | 2 | IPR000573 | |
| Domain | Aconitase_C | 2.49e-04 | 3 | 171 | 2 | PF00694 | |
| Domain | - | 2.49e-04 | 3 | 171 | 2 | 3.30.499.10 | |
| Domain | Acoase/IPM_deHydtase_lsu_aba | 2.49e-04 | 3 | 171 | 2 | IPR001030 | |
| Domain | - | 2.49e-04 | 3 | 171 | 2 | 3.40.1060.10 | |
| Domain | - | 2.49e-04 | 3 | 171 | 2 | 3.20.19.10 | |
| Domain | Acoase/IPM_deHydtase | 2.49e-04 | 3 | 171 | 2 | IPR015937 | |
| Domain | Acnase/IPM_dHydase_lsu_aba_1/3 | 2.49e-04 | 3 | 171 | 2 | IPR015931 | |
| Domain | Aconitase/IPMdHydase_lsu_aba_2 | 2.49e-04 | 3 | 171 | 2 | IPR015932 | |
| Domain | ACONITASE_1 | 2.49e-04 | 3 | 171 | 2 | PS00450 | |
| Domain | Aconitase/3IPM_dehydase_swvl | 2.49e-04 | 3 | 171 | 2 | IPR015928 | |
| Domain | Aconitase | 2.49e-04 | 3 | 171 | 2 | PF00330 | |
| Domain | Aconitase_4Fe-4S_BS | 2.49e-04 | 3 | 171 | 2 | IPR018136 | |
| Domain | ACONITASE_2 | 2.49e-04 | 3 | 171 | 2 | PS01244 | |
| Domain | Growth_fac_rcpt_ | 5.92e-04 | 156 | 171 | 7 | IPR009030 | |
| Domain | FYrich_C | 8.18e-04 | 5 | 171 | 2 | IPR003889 | |
| Domain | FYrich_N | 8.18e-04 | 5 | 171 | 2 | IPR003888 | |
| Domain | FYRC | 8.18e-04 | 5 | 171 | 2 | SM00542 | |
| Domain | FYRN | 8.18e-04 | 5 | 171 | 2 | SM00541 | |
| Domain | FYRN | 8.18e-04 | 5 | 171 | 2 | PF05964 | |
| Domain | FYRC | 8.18e-04 | 5 | 171 | 2 | PF05965 | |
| Domain | FYRC | 8.18e-04 | 5 | 171 | 2 | PS51543 | |
| Domain | FYRN | 8.18e-04 | 5 | 171 | 2 | PS51542 | |
| Domain | EPHD | 1.02e-03 | 22 | 171 | 3 | PS51805 | |
| Domain | Spectrin | 1.17e-03 | 23 | 171 | 3 | PF00435 | |
| Domain | EF-hand_dom_typ1 | 1.22e-03 | 6 | 171 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 1.22e-03 | 6 | 171 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 1.22e-03 | 6 | 171 | 2 | PF09068 | |
| Domain | EF-hand_3 | 1.22e-03 | 6 | 171 | 2 | PF09069 | |
| Domain | Galactose-bd-like | 1.73e-03 | 94 | 171 | 5 | IPR008979 | |
| Pathway | REACTOME_KINESINS | 9.48e-05 | 57 | 114 | 5 | MM15714 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.21e-04 | 60 | 114 | 5 | MM15636 | |
| Pathway | REACTOME_KINESINS | 1.31e-04 | 61 | 114 | 5 | M977 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.42e-04 | 62 | 114 | 5 | M546 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 HIVEP1 EP400 BCL7B CHD8 POGZ MORC4 UBN2 KMT2C BCL11B OTX2 ARID2 ZNF644 ZMIZ2 NFRKB SEC16A KMT2A ASXL2 ZHX1 | 2.42e-14 | 351 | 176 | 19 | 38297188 |
| Pubmed | TET2 FLG ARHGAP32 RBM11 HIVEP1 EP400 ACO2 SPTBN1 BCL7B HIPK2 CHD8 POGZ MLLT10 MORC4 UBN2 RFX1 YEATS2 KMT2C JUN BRD2 BRCA1 ARID2 ZNF644 ZMIZ2 NFRKB SEC16A MARF1 KMT2A N4BP1 ASXL2 PUM1 SAP130 ZHX1 | 2.52e-13 | 1429 | 176 | 33 | 35140242 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RBM11 HIVEP1 CHAF1A ZNF280C KIF4A DAXX CHD8 POGZ UBN2 RFX1 DNTTIP2 FBXO38 SCML2 BRD2 BRCA1 ARID2 ZNF644 NFRKB KMT2A BOD1L1 KIF18B ZHX1 | 6.94e-13 | 608 | 176 | 22 | 36089195 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HIVEP1 EP400 CHAF1A KIF1B SPTBN1 DAXX POGZ RFX1 GSK3B FBXO38 YEATS2 PASK JUN ABLIM1 SCML2 BRD2 ANAPC1 CBFA2T2 ZNF644 NFRKB SEC16A KMT2A ATM ZHX1 | 1.55e-12 | 774 | 176 | 24 | 15302935 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RBM11 HIVEP1 EP400 CHAF1A ZNF280C KIF4A CHD8 POGZ UBN2 RFX1 DNTTIP2 YEATS2 JUN SCML2 BRD2 BRCA1 ARID2 ZNF644 NFRKB SEC16A MARF1 KMT2A BOD1L1 KIF18B PUM1 SAP130 | 3.07e-12 | 954 | 176 | 26 | 36373674 |
| Pubmed | EP400 KIF1B ALS2 POGZ C2CD2L ZCCHC14 YEATS2 ABLIM1 ZNF644 TLN1 SEC16A COBL BOD1L1 ASXL2 ANKRD12 PUM1 TET3 ARHGAP21 | 3.60e-12 | 407 | 176 | 18 | 12693553 | |
| Pubmed | EP400 MPDZ KIF4A CHD8 POGZ UBN2 RFX1 YEATS2 KMT2C ABLIM1 SCML2 MRTFB ANAPC1 ARID2 TLN1 NFRKB SEC16A KMT2A BOD1L1 SAP130 | 7.31e-12 | 549 | 176 | 20 | 38280479 | |
| Pubmed | ARHGAP32 CRTC3 HIVEP1 CHAF1A SPTBN1 HIPK2 LAMB2 DAXX CHD8 NCKAP5 POGZ KMT2C JUN ABLIM1 KIAA1549L ARID2 COBL BICRAL ZHX1 | 7.50e-12 | 486 | 176 | 19 | 20936779 | |
| Pubmed | ZXDC HIVEP1 EP400 CHD8 MORC4 FBXO38 YEATS2 BRCA1 ZNF644 NFRKB ZHX1 | 2.02e-11 | 116 | 176 | 11 | 30804394 | |
| Pubmed | TET2 RBM11 HIVEP1 ZGRF1 CHD8 POGZ MORC4 RFX1 YEATS2 MRTFB ANAPC1 ZNF644 ZMIZ2 SEC16A UTRN ARHGAP21 S100PBP | 5.45e-11 | 418 | 176 | 17 | 34709266 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRUNE2 ARHGAP32 CRTC3 AFF2 EP400 MLLT10 MRTFB TULP4 ARID2 CBFA2T2 SCN1A ZMIZ2 TLN1 ATM EIF4G3 SAP130 ZHX1 | 8.44e-11 | 430 | 176 | 17 | 35044719 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 ARHGAP32 CRTC3 HIVEP1 KIF1B SPTBN1 MPDZ ALS2 PRAG1 ZCCHC14 ABLIM1 SEC16A KMT2A COBL BOD1L1 SSH2 EIF4G3 PUM1 UTRN SH3RF3 ARHGAP21 OTOG | 5.53e-10 | 861 | 176 | 22 | 36931259 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | CACNA1B AFF2 SZT2 LAMA1 YEATS2 KMT2C TLN1 PKHD1 KMT2A COBL BOD1L1 OTOG | 8.11e-10 | 208 | 176 | 12 | 33230847 |
| Pubmed | TET2 HIVEP1 EP400 BCL7B KIF4A CHD8 MORC4 UBN2 JUN SCML2 NFRKB KMT2A SAP130 | 1.31e-09 | 268 | 176 | 13 | 33640491 | |
| Pubmed | TET2 HIVEP1 EP400 BCL7B KIF4A CHD8 POGZ UBN2 RFX1 GSK3B YEATS2 KMT2C JUN BRCA1 ARID2 ZNF644 ZMIZ2 TLN1 NFRKB SCP2 KMT2A BICRAL ASXL2 SAP130 | 2.08e-09 | 1103 | 176 | 24 | 34189442 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | ZXDC HIVEP1 CHAF1A ZNF280C POGZ MORC4 FBXO38 YEATS2 KMT2C BRD2 ANAPC1 ZNF644 NFRKB KMT2A BOD1L1 ASXL2 | 5.55e-09 | 495 | 176 | 16 | 27705803 |
| Pubmed | EP400 CHAF1A BCL7B KIAA1549 PEX6 CHD8 POGZ BRWD3 DNTTIP2 C2CD2L YEATS2 PASK BCL11B TC2N BRD2 BRCA1 ANAPC1 ARID2 NFRKB SEC16A BICRAL KIF18B SAP130 | 1.27e-08 | 1116 | 176 | 23 | 31753913 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TET2 HIVEP1 EP400 POGZ MORC4 YEATS2 KMT2C BCL11B BRD2 ARID2 ZMIZ2 NFRKB SEC16A BICRAL | 1.82e-08 | 398 | 176 | 14 | 35016035 |
| Pubmed | PRUNE2 ALS2 CHD8 C2CD2L ZCCHC14 PASK KMT2C ABLIM1 MRTFB TLN1 SEC16A | 2.34e-08 | 225 | 176 | 11 | 12168954 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZXDC PCSK5 EP400 KALRN SZT2 PEX6 LAMB2 CHD8 MLLT10 PRAG1 C2CD2L ZCCHC14 KMT2C JUN BRD2 TULP4 ZMIZ2 TLN1 SEC16A COBL PUM1 ARHGAP21 | 4.95e-08 | 1105 | 176 | 22 | 35748872 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | RBM11 HIVEP1 EP400 ZGRF1 KIF1B HIPK2 DAXX MORC4 UBN2 GSK3B YEATS2 MRTFB ANAPC1 ARID2 ZNF644 SEC16A | 6.05e-08 | 588 | 176 | 16 | 38580884 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | EP400 SPTBN1 KIF4A DAXX CHD8 POGZ SCML2 BRD2 ANAPC1 ARID2 KMT2A KIF18B UTRN | 1.25e-07 | 394 | 176 | 13 | 27248496 |
| Pubmed | EP400 CHAF1A MPDZ KIF4A LAMB2 DAXX CHD8 UBN2 CEP164 C2CD2L KMT2C ABLIM1 SCML2 MRTFB BRD2 BRCA1 ANAPC1 ARID2 TLN1 CXXC4 NFRKB KMT2A EIF4G3 UTRN ZHX1 | 1.65e-07 | 1497 | 176 | 25 | 31527615 | |
| Pubmed | ZXDC HIVEP1 ZNF280C POGZ MLLT10 RUNX3 RFX1 HINFP ZCCHC14 JUN ABLIM1 OTX2 BRD2 ZIC5 ARID2 ZNF644 ZMIZ2 TBX5 | 1.75e-07 | 808 | 176 | 18 | 20412781 | |
| Pubmed | 2.21e-07 | 222 | 176 | 10 | 37071664 | ||
| Pubmed | EP400 CHAF1A MPDZ KIF4A C2CD2L ZCCHC14 YEATS2 ABLIM1 SCML2 ANAPC1 NFRKB SEC16A DNAJC5 BOD1L1 N4BP1 ATL2 PUM1 | 2.23e-07 | 733 | 176 | 17 | 34672954 | |
| Pubmed | EPHB6 PCSK5 CRTC3 RBM11 ZGRF1 PKD1L1 HIPK2 LAMB2 RIOX1 CHD8 JMY ZCCHC14 BRD2 ZIC5 ARID2 CBFA2T2 MARF1 EIF4G3 PUM1 RIMS2 UTRN ZHX1 | 2.53e-07 | 1215 | 176 | 22 | 15146197 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SPTBN1 PCDHB6 KMT2C ARID2 KIF19 KMT2A COBL RBM46 ATM GALNT5 PUM1 MUC4 SH3RF3 ARHGAP21 | 2.77e-07 | 497 | 176 | 14 | 36774506 |
| Pubmed | STARD13 HIVEP1 SPTBN1 MCAM PEX6 LAMB2 PPP1R15A MORC4 RFX1 MRTFB RNPEP ASXL2 PUM1 UTRN SAP130 | 3.86e-07 | 591 | 176 | 15 | 15231748 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 CPAMD8 KIZ KIF1B HIPK2 GRIK1 GRIK2 UBN2 BRWD3 YEATS2 KMT2C ABLIM1 MRTFB TULP4 CBFA2T2 SCP2 COBL BOD1L1 ANKRD12 EIF4G3 UTRN SAP130 SH3RF3 TET3 | 5.63e-07 | 1489 | 176 | 24 | 28611215 |
| Pubmed | ZXDC HIVEP1 KIF1B POGZ MLLT10 ZBBX ZCCHC14 KMT2C JUN ABLIM1 BCL11B OTX2 BRD2 BRCA1 ZMIZ2 KMT2A | 7.38e-07 | 709 | 176 | 16 | 22988430 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EP400 CHAF1A SPTBN1 KIF4A DAXX CHD8 FBXO38 ANAPC1 ARID2 TLN1 BOD1L1 | 1.15e-06 | 332 | 176 | 11 | 32786267 |
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 1.20e-06 | 37 | 176 | 5 | 11416179 | |
| Pubmed | EP400 CHD8 POGZ DNTTIP2 YEATS2 BRD2 BRCA1 NFRKB KMT2A N4BP1 SAP130 | 1.41e-06 | 339 | 176 | 11 | 30415952 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.83e-06 | 18 | 176 | 4 | 18834073 | |
| Pubmed | Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity. | 2.52e-06 | 6 | 176 | 3 | 32572241 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EP400 CHAF1A KIF4A POGZ UBN2 DNTTIP2 YEATS2 KMT2C JUN SCML2 BRD2 BRCA1 ZIC5 ANAPC1 ZNF644 NFRKB KMT2A ASXL2 KIF18B SAP130 TET3 | 2.75e-06 | 1294 | 176 | 21 | 30804502 |
| Pubmed | PCSK5 ARHGAP32 FAT4 RBM11 HIVEP1 KALRN ACO2 OTX2 KIAA1549L BRCA1 CBFA2T2 IGHM PUM1 ZHX1 | 2.96e-06 | 608 | 176 | 14 | 16713569 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | CHAF1A DAXX CHD8 POGZ MLLT10 JMY DNTTIP2 SCML2 BRD2 ANAPC1 NFRKB SCP2 KMT2A | 3.64e-06 | 533 | 176 | 13 | 30554943 |
| Pubmed | EP400 ZNF280C CHD8 RFX1 YEATS2 JUN ABLIM1 SCML2 ARID2 SEC16A SAP130 ARHGAP21 | 5.74e-06 | 472 | 176 | 12 | 38943005 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RBM11 EP400 ZNF280C KIF4A DNTTIP2 YEATS2 ABLIM1 SCML2 MRTFB ARID2 TLN1 SEC16A KMT2A BOD1L1 EIF4G3 UTRN ARHGAP21 | 5.95e-06 | 934 | 176 | 17 | 33916271 |
| Pubmed | SPTBN1 KIF4A CHD8 POGZ DNTTIP2 RNPEP ANAPC1 TLN1 SEC16A KMT2A ATM EIF4G3 PUM1 UTRN | 6.69e-06 | 653 | 176 | 14 | 22586326 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 7.93e-06 | 197 | 176 | 8 | 20811636 | |
| Pubmed | 7.93e-06 | 197 | 176 | 8 | 36604605 | ||
| Pubmed | ARHGAP32 KALRN SPTBN1 ANKS1B MPDZ KIF4A CHD8 GRIK2 UBN2 GSK3B ABLIM1 BCL11B ANAPC1 SEC16A KIF4B SSH2 ARHGAP21 | 8.85e-06 | 963 | 176 | 17 | 28671696 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.01e-05 | 146 | 176 | 7 | 23892456 | |
| Pubmed | 1.02e-05 | 27 | 176 | 4 | 29374058 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.21e-05 | 150 | 176 | 7 | 28242625 | |
| Pubmed | ARHGAP32 KALRN ACO2 KIF1B SPTBN1 ANKS1B KIAA1549 JMY GSK3B CDKL5 ABLIM1 RNPEP PTPRZ1 IGHM TLN1 SEC16A KMT2A SSH2 EIF4G3 UTRN ARHGAP21 | 1.27e-05 | 1431 | 176 | 21 | 37142655 | |
| Pubmed | STARD13 FLG ACO2 CHAF1A SPTBN1 ANKS1B DNTTIP2 BRD2 BRCA1 SYCP1 MARF1 PKHD1 KMT2A DNAJC5 BOD1L1 ATM EIF4G3 RIMS2 CEP57 ARHGAP21 CCDC158 | 1.42e-05 | 1442 | 176 | 21 | 35575683 | |
| Pubmed | DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants. | 1.49e-05 | 10 | 176 | 3 | 29276034 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.53e-05 | 283 | 176 | 9 | 30585729 | |
| Pubmed | 1.57e-05 | 30 | 176 | 4 | 31043422 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.77e-05 | 363 | 176 | 10 | 14691545 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | EP400 MCAM DAXX CHD8 UBN2 DNTTIP2 YEATS2 ABLIM1 TLN1 NFRKB SEC16A | 1.80e-05 | 444 | 176 | 11 | 34795231 |
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 2.55e-05 | 2 | 176 | 2 | 36482480 | |
| Pubmed | Mechanisms of increased risk of tumorigenesis in Atm and Brca1 double heterozygosity. | 2.55e-05 | 2 | 176 | 2 | 21849032 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 24680865 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 14724198 | ||
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 2.55e-05 | 2 | 176 | 2 | 30081192 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 15539395 | ||
| Pubmed | Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma. | 2.55e-05 | 2 | 176 | 2 | 27852070 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 8620001 | ||
| Pubmed | Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. | 2.55e-05 | 2 | 176 | 2 | 8260617 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 25518808 | ||
| Pubmed | Cellular motor protein KIF-4 associates with retroviral Gag. | 2.55e-05 | 2 | 176 | 2 | 10559369 | |
| Pubmed | Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses. | 2.55e-05 | 2 | 176 | 2 | 15537878 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 32367481 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 21565503 | ||
| Pubmed | Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer. | 2.55e-05 | 2 | 176 | 2 | 38012744 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 15358807 | ||
| Pubmed | Comparison of collagen propeptides as growth markers in children with inflammatory bowel disease. | 2.55e-05 | 2 | 176 | 2 | 2001833 | |
| Pubmed | Intrinsic and extrinsic connections of Tet3 dioxygenase with CXXC zinc finger modules. | 2.55e-05 | 2 | 176 | 2 | 23690950 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 25486566 | ||
| Pubmed | The aconitase family: three structural variations on a common theme. | 2.55e-05 | 2 | 176 | 2 | 9020582 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 3182802 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 11069933 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 18243662 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 12947409 | ||
| Pubmed | Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. | 2.55e-05 | 2 | 176 | 2 | 18806775 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 21570970 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 10773663 | ||
| Pubmed | Specificity of MLL1 and TET3 CXXC domains towards naturally occurring cytosine modifications. | 2.55e-05 | 2 | 176 | 2 | 30352306 | |
| Pubmed | Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. | 2.55e-05 | 2 | 176 | 2 | 23563267 | |
| Pubmed | Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. | 2.55e-05 | 2 | 176 | 2 | 8700852 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 28350061 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 34058791 | ||
| Pubmed | TET proteins regulate Drosha expression and impact microRNAs in iNKT cells. | 2.55e-05 | 2 | 176 | 2 | 39364402 | |
| Pubmed | Q/R site editing controls kainate receptor inhibition by membrane fatty acids. | 2.55e-05 | 2 | 176 | 2 | 16221857 | |
| Pubmed | Role for ATM in DNA damage-induced phosphorylation of BRCA1. | 2.55e-05 | 2 | 176 | 2 | 10866324 | |
| Pubmed | Subunit composition and alternative splicing regulate membrane delivery of kainate receptors. | 2.55e-05 | 2 | 176 | 2 | 15014126 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 16204043 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 27729528 | ||
| Pubmed | Structural basis for the ATP-induced isomerization of kinesin. | 2.55e-05 | 2 | 176 | 2 | 23500491 | |
| Pubmed | Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells. | 2.55e-05 | 2 | 176 | 2 | 26657054 | |
| Pubmed | Functional characterization of kainate receptors in the mouse nucleus accumbens. | 2.55e-05 | 2 | 176 | 2 | 11985817 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 14678985 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 15673679 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 11182092 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 37420018 | ||
| Interaction | ASF1A interactions | HIVEP1 EP400 CHAF1A CHD8 POGZ UBN2 FBXO38 YEATS2 JUN BRD2 BRCA1 ARID2 ZNF644 NFRKB KMT2A KIF18B SAP130 | 4.82e-11 | 249 | 172 | 17 | int:ASF1A |
| Interaction | CRX interactions | TET2 EP400 SZT2 BCL7B POGZ MORC4 UBN2 ZIC1 KMT2C OTX2 ARID2 ZNF644 ZMIZ2 NFRKB ASXL2 ATM ZHX1 | 6.58e-11 | 254 | 172 | 17 | int:CRX |
| Interaction | FEV interactions | HIVEP1 EP400 BCL7B POGZ MLLT10 MORC4 UBN2 RFX1 KMT2C ARID2 ZNF644 NFRKB KMT2A ASXL2 ZHX1 | 2.31e-10 | 203 | 172 | 15 | int:FEV |
| Interaction | EGR2 interactions | TET2 HIVEP1 EP400 POGZ MORC4 UBN2 KMT2C BCL11B ARID2 ZNF644 ZMIZ2 NFRKB SEC16A KMT2A | 2.43e-10 | 171 | 172 | 14 | int:EGR2 |
| Interaction | H3-3A interactions | RBM11 HIVEP1 CHAF1A ZNF280C KIF4A DAXX CHD8 POGZ UBN2 RFX1 BRWD3 DNTTIP2 FBXO38 KMT2C SCML2 BRD2 BRCA1 ARID2 ZNF644 NFRKB KMT2A BOD1L1 KIF18B SAP130 ZHX1 | 5.50e-09 | 749 | 172 | 25 | int:H3-3A |
| Interaction | H2BC21 interactions | EP400 CHAF1A ZNF280C HIPK2 KIF4A DAXX CHD8 POGZ MLLT10 DNTTIP2 C2CD2L YEATS2 SCML2 MRTFB KIAA1549L BRD2 BRCA1 PTPRM ANAPC1 ARID2 ZNF644 TLN1 KMT2A KIF18B | 6.13e-09 | 696 | 172 | 24 | int:H2BC21 |
| Interaction | HNF1B interactions | TET2 HIVEP1 EP400 POGZ MLLT10 MORC4 UBN2 KMT2C OTX2 ARID2 NFRKB ASXL2 SAP130 | 9.69e-09 | 190 | 172 | 13 | int:HNF1B |
| Interaction | NFIX interactions | HIVEP1 EP400 POGZ RFX1 TIPARP KMT2C JUN OTX2 BRD2 ARID2 ZNF644 NFRKB KMT2A SAP130 | 9.73e-09 | 227 | 172 | 14 | int:NFIX |
| Interaction | KLF5 interactions | TET2 FLG RBM11 HIVEP1 EP400 BCL7B MLLT10 MORC4 GSK3B KMT2C JUN ARID2 SEC16A | 1.32e-08 | 195 | 172 | 13 | int:KLF5 |
| Interaction | CBX3 interactions | EP400 CHAF1A ZNF280C HIPK2 KIF4A DAXX CHD8 POGZ UBN2 RFX1 DNTTIP2 TIPARP YEATS2 SCML2 BRD2 BRCA1 ARID2 ZNF644 NFRKB KMT2A ASXL2 SAP130 | 3.48e-08 | 646 | 172 | 22 | int:CBX3 |
| Interaction | FBXO38 interactions | ZXDC HIVEP1 EP400 CHD8 MORC4 FBXO38 YEATS2 BRCA1 ZNF644 NFRKB ZHX1 | 4.78e-08 | 145 | 172 | 11 | int:FBXO38 |
| Interaction | SP7 interactions | TET2 RBM11 HIVEP1 EP400 BCL7B POGZ MORC4 RFX1 GSK3B KMT2C BRCA1 ARID2 ZMIZ2 N4BP1 SAP130 | 5.61e-08 | 304 | 172 | 15 | int:SP7 |
| Interaction | NUP43 interactions | RBM11 HIVEP1 EP400 SZT2 ZNF280C CHD8 POGZ UBN2 DNTTIP2 YEATS2 MRTFB BRCA1 ARID2 ZNF644 NFRKB MARF1 KMT2A BOD1L1 ASXL2 EIF4G3 ZHX1 | 9.17e-08 | 625 | 172 | 21 | int:NUP43 |
| Interaction | SMC5 interactions | RBM11 HIVEP1 EP400 CHAF1A ZNF280C KIF4A CHD8 POGZ UBN2 RFX1 DNTTIP2 TIPARP YEATS2 JUN SCML2 BRD2 BRCA1 ARID2 ZNF644 NFRKB SEC16A MARF1 KMT2A BOD1L1 KIF18B PUM1 SAP130 | 1.05e-07 | 1000 | 172 | 27 | int:SMC5 |
| Interaction | TLE3 interactions | TET2 CRTC3 RBM11 HIVEP1 MLLT10 UBN2 GSK3B HINFP BCL11B ARID2 ZMIZ2 NFRKB AGFG2 KMT2A ASXL2 SAP130 | 1.52e-07 | 376 | 172 | 16 | int:TLE3 |
| Interaction | H3C3 interactions | HIVEP1 CHAF1A ZNF280C KIF4A DAXX CHD8 POGZ DNTTIP2 FBXO38 SCML2 BRD2 BRCA1 ARID2 ZNF644 NFRKB KMT2A BOD1L1 KIF18B | 2.57e-07 | 495 | 172 | 18 | int:H3C3 |
| Interaction | PHF21A interactions | RBM11 HIVEP1 ZGRF1 CHD8 MORC4 TIPARP YEATS2 JUN MRTFB ANAPC1 ZMIZ2 SEC16A UTRN ARHGAP21 S100PBP | 2.68e-07 | 343 | 172 | 15 | int:PHF21A |
| Interaction | EN1 interactions | 4.32e-07 | 110 | 172 | 9 | int:EN1 | |
| Interaction | PAX6 interactions | HIVEP1 EP400 CHAF1A BCL7B HIPK2 POGZ MORC4 UBN2 KMT2C ARID2 ZNF644 NFRKB ASXL2 SAP130 ZHX1 | 6.10e-07 | 366 | 172 | 15 | int:PAX6 |
| Interaction | YAP1 interactions | CRTC3 SPTBN1 MPDZ KIF4A CHD8 POGZ RUNX3 UBN2 RFX1 GSK3B TIPARP KMT2C JUN ABLIM1 SCML2 MRTFB BRD2 TULP4 ANAPC1 ARID2 SCN1A TLN1 NFRKB SEC16A KMT2A BOD1L1 SAP130 | 6.34e-07 | 1095 | 172 | 27 | int:YAP1 |
| Interaction | KLF3 interactions | HIVEP1 EP400 POGZ MORC4 UBN2 OTX2 ARID2 ZNF644 NFRKB KMT2A SAP130 ZHX1 | 6.34e-07 | 228 | 172 | 12 | int:KLF3 |
| Interaction | HNF4A interactions | HIVEP1 EP400 POGZ UBN2 YEATS2 KMT2C BRD2 ARID2 ZNF644 NFRKB ASXL2 SAP130 ZHX1 | 7.24e-07 | 275 | 172 | 13 | int:HNF4A |
| Interaction | SUMO2 interactions | EP400 KALRN ACO2 CHAF1A SPTBN1 HIPK2 KIF4A DAXX CHD8 POGZ FBXO38 JUN BRCA1 ANAPC1 ARID2 TLN1 BOD1L1 KIF18B ZHX1 | 7.63e-07 | 591 | 172 | 19 | int:SUMO2 |
| Interaction | HDAC1 interactions | TET2 RBM11 HIVEP1 EP400 ZGRF1 CHAF1A KIF4A DAXX CHD8 MORC4 RUNX3 RFX1 TIPARP YEATS2 JUN BCL11B MRTFB BRCA1 ZMIZ2 TLN1 KMT2A ATM UTRN SAP130 ZHX1 ARHGAP21 S100PBP | 7.96e-07 | 1108 | 172 | 27 | int:HDAC1 |
| Interaction | ELF1 interactions | 1.36e-06 | 126 | 172 | 9 | int:ELF1 | |
| Interaction | KDM1A interactions | TET2 RBM11 HIVEP1 EP400 ZGRF1 CHAF1A ZNF280C CHD8 POGZ MORC4 RFX1 GSK3B TIPARP YEATS2 MRTFB BRCA1 ANAPC1 ZNF644 SEC16A CEP57 UTRN ARHGAP21 TBX5 S100PBP | 1.60e-06 | 941 | 172 | 24 | int:KDM1A |
| Interaction | H2BC3 interactions | EP400 SPTBN1 KIF4A DAXX CHD8 POGZ KMT2C SCML2 BRD2 BRCA1 ANAPC1 ARID2 KMT2A KIF18B UTRN | 2.22e-06 | 406 | 172 | 15 | int:H2BC3 |
| Interaction | YWHAH interactions | TET2 ARHGAP32 CRTC3 HIVEP1 KIF1B SPTBN1 MPDZ ALS2 PRAG1 ZCCHC14 JUN ABLIM1 RNPEP SEC16A KMT2A COBL BOD1L1 SSH2 EIF4G3 PUM1 RIMS2 UTRN SH3RF3 ARHGAP21 OTOG | 7.51e-06 | 1102 | 172 | 25 | int:YWHAH |
| Interaction | ETS1 interactions | 9.49e-06 | 121 | 172 | 8 | int:ETS1 | |
| Interaction | SMARCA4 interactions | EP400 CHAF1A BCL7B TIPARP SCML2 BCL11B CSF1 BRD2 BRCA1 ARID2 ZMIZ2 BICRAL ATM ATL2 TBX5 | 1.05e-05 | 462 | 172 | 15 | int:SMARCA4 |
| Interaction | AR interactions | TET2 HIVEP1 EP400 BCL7B HIPK2 KIF4A DAXX CHD8 MORC4 UBN2 GSK3B TIPARP KMT2C JUN SCML2 BRD2 BRCA1 ARID2 ZMIZ2 NFRKB SEC16A KMT2A SAP130 | 1.28e-05 | 992 | 172 | 23 | int:AR |
| Interaction | NFIC interactions | TET2 HIVEP1 POGZ MORC4 RFX1 ZCCHC14 BRCA1 ZNF644 SAP130 ZHX1 | 1.35e-05 | 210 | 172 | 10 | int:NFIC |
| Interaction | SYNGAP1 interactions | STARD13 ARHGAP32 KALRN ACO2 SPTBN1 ANKS1B MPDZ GSK3B CDKL5 ABLIM1 EIF4G3 ARHGAP21 | 1.36e-05 | 307 | 172 | 12 | int:SYNGAP1 |
| Interaction | FBXO42 interactions | RBM11 HIVEP1 EP400 KIF1B GSK3B YEATS2 MRTFB ANAPC1 ARID2 ZNF644 SEC16A | 1.46e-05 | 259 | 172 | 11 | int:FBXO42 |
| Interaction | SMARCB1 interactions | CHAF1A BCL7B MLLT10 PPP1R15A KMT2C JUN SCML2 OTX2 BRD2 BRCA1 ARID2 KMT2A ATM | 1.54e-05 | 364 | 172 | 13 | int:SMARCB1 |
| Interaction | ADD1 interactions | 1.66e-05 | 171 | 172 | 9 | int:ADD1 | |
| Interaction | TERF2IP interactions | HIVEP1 EP400 CHAF1A ZNF280C BCL7B KIF4A CHD8 POGZ RFX1 YEATS2 BRCA1 ZNF644 NFRKB KMT2A BOD1L1 SAP130 | 2.15e-05 | 552 | 172 | 16 | int:TERF2IP |
| Interaction | ERG interactions | 2.26e-05 | 223 | 172 | 10 | int:ERG | |
| Interaction | KLF8 interactions | HIVEP1 EP400 POGZ UBN2 YEATS2 BRD2 ARID2 ZNF644 NFRKB SEC16A SAP130 ZHX1 | 2.69e-05 | 329 | 172 | 12 | int:KLF8 |
| Interaction | LHX1 interactions | 2.91e-05 | 103 | 172 | 7 | int:LHX1 | |
| Interaction | LHX3 interactions | 3.10e-05 | 185 | 172 | 9 | int:LHX3 | |
| Interaction | YY1 interactions | HIVEP1 EP400 CHD8 POGZ CEP164 YEATS2 BRD2 BRCA1 ARID2 ZNF644 NFRKB KMT2A ASXL2 ZHX1 | 3.68e-05 | 454 | 172 | 14 | int:YY1 |
| Interaction | HCFC1 interactions | EP400 CHD8 TIPARP YEATS2 KMT2C JUN BRCA1 KMT2A BOD1L1 ASXL2 TBX5 | 4.52e-05 | 293 | 172 | 11 | int:HCFC1 |
| Interaction | SMAD1 interactions | 4.69e-05 | 243 | 172 | 10 | int:SMAD1 | |
| Interaction | CTNNB1 interactions | ARHGAP32 EP400 ACO2 MCAM MPDZ CHD8 GRIK2 MLLT10 GSK3B CDKL5 JUN BRCA1 PTPRM PTPRZ1 ZMIZ2 TLN1 SEC16A KMT2A DNAJC5 ASXL2 UTRN ARHGAP21 | 5.06e-05 | 1009 | 172 | 22 | int:CTNNB1 |
| Interaction | USP7 interactions | TET2 RBM11 NXPE4 ZGRF1 SPTBN1 ZNF280C VSTM2A LAMA1 DAXX BRWD3 GSK3B TIPARP ZBBX SHROOM4 CDKL5 FBXO38 SCML2 CSF1 NALF1 KIAA1549L BRCA1 ZMIZ2 SYCP1 UTRN SAP130 TBX5 | 5.07e-05 | 1313 | 172 | 26 | int:USP7 |
| Interaction | KCNA3 interactions | CACNA1B ARHGAP32 AFF2 SZT2 KIF1B SPTBN1 LAMA1 MPDZ YEATS2 KMT2C ABLIM1 TLN1 SEC16A PKHD1 KMT2A COBL BOD1L1 EIF4G3 ARHGAP21 OTOG | 5.62e-05 | 871 | 172 | 20 | int:KCNA3 |
| Interaction | CEBPA interactions | TET2 HIVEP1 EP400 SPTBN1 BCL7B KIF4A CHD8 POGZ UBN2 RFX1 GSK3B YEATS2 KMT2C JUN BRCA1 ARID2 ZNF644 ZMIZ2 TLN1 NFRKB SCP2 KMT2A BICRAL ASXL2 SAP130 | 5.75e-05 | 1245 | 172 | 25 | int:CEBPA |
| Interaction | ELF4 interactions | 5.90e-05 | 115 | 172 | 7 | int:ELF4 | |
| Interaction | ELF2 interactions | 5.94e-05 | 156 | 172 | 8 | int:ELF2 | |
| Interaction | TBXT interactions | 6.23e-05 | 116 | 172 | 7 | int:TBXT | |
| Interaction | CREB1 interactions | 6.80e-05 | 254 | 172 | 10 | int:CREB1 | |
| Interaction | ETV7 interactions | 7.71e-05 | 27 | 172 | 4 | int:ETV7 | |
| Interaction | ELK3 interactions | 7.73e-05 | 120 | 172 | 7 | int:ELK3 | |
| Interaction | KDM6A interactions | 7.74e-05 | 162 | 172 | 8 | int:KDM6A | |
| Interaction | PAX2 interactions | 8.87e-05 | 85 | 172 | 6 | int:PAX2 | |
| Interaction | H3C1 interactions | FAT4 ACO2 CHAF1A ZNF280C KIF4A DAXX CHD8 POGZ UBN2 GSK3B DNTTIP2 KMT2C BRD2 ANAPC1 ARID2 ZNF644 PCDH11X KMT2A ATM KIF18B | 8.94e-05 | 901 | 172 | 20 | int:H3C1 |
| Interaction | RCOR1 interactions | RBM11 HIVEP1 ZGRF1 LAMB2 CHD8 MORC4 YEATS2 MRTFB ANAPC1 SEC16A UTRN ARHGAP21 TBX5 S100PBP | 9.09e-05 | 494 | 172 | 14 | int:RCOR1 |
| Interaction | LHX4 interactions | 9.18e-05 | 166 | 172 | 8 | int:LHX4 | |
| Interaction | ADNP2 interactions | 9.63e-05 | 54 | 172 | 5 | int:ADNP2 | |
| Interaction | SIN3A interactions | TET2 ACO2 CHAF1A KIF4A DAXX TIPARP CBFA2T2 KMT2A BOD1L1 ATM SAP130 TBX5 | 1.07e-04 | 380 | 172 | 12 | int:SIN3A |
| Interaction | SETD1A interactions | 1.08e-04 | 170 | 172 | 8 | int:SETD1A | |
| Interaction | TNIK interactions | ARHGAP32 KALRN SPTBN1 MCAM CHD8 GRIK2 UBN2 GSK3B CDKL5 ABLIM1 BCL11B ARHGAP21 | 1.10e-04 | 381 | 172 | 12 | int:TNIK |
| Interaction | H2AC4 interactions | EP400 ACO1 SPTBN1 DAXX CHD8 POGZ KMT2C SCML2 BRD2 BRCA1 ANAPC1 ARID2 KMT2A KIF18B | 1.17e-04 | 506 | 172 | 14 | int:H2AC4 |
| Interaction | H2BC8 interactions | EP400 CHAF1A ZNF280C KIF4A CHD8 POGZ DNTTIP2 SCML2 BRD2 BRCA1 ZNF644 NFRKB SEC16A KMT2A KIF18B | 1.30e-04 | 576 | 172 | 15 | int:H2BC8 |
| Interaction | DLG4 interactions | ARHGAP32 KALRN KIF1B SPTBN1 ANKS1B ALS2 GRIK1 GRIK2 CDKL5 ABLIM1 TULP4 ATL2 SH3RF3 | 1.32e-04 | 449 | 172 | 13 | int:DLG4 |
| Interaction | CXXC1 interactions | 1.41e-04 | 132 | 172 | 7 | int:CXXC1 | |
| Interaction | PML interactions | TET2 EP400 MCAM HIPK2 DAXX CHD8 RUNX3 UBN2 DNTTIP2 TIPARP YEATS2 JUN ABLIM1 BRCA1 TLN1 NFRKB SEC16A KMT2A ATM SAP130 | 1.43e-04 | 933 | 172 | 20 | int:PML |
| Interaction | NFYC interactions | 1.43e-04 | 177 | 172 | 8 | int:NFYC | |
| Interaction | YWHAG interactions | TET2 ARHGAP32 CRTC3 HIVEP1 CHAF1A KIF1B SPTBN1 MPDZ ALS2 PRAG1 DNTTIP2 C2CD2L ABLIM1 SEC16A KMT2A COBL BOD1L1 SSH2 EIF4G3 PUM1 UTRN SH3RF3 ARHGAP21 OTOG | 1.59e-04 | 1248 | 172 | 24 | int:YWHAG |
| Interaction | MAPRE3 interactions | 1.65e-04 | 230 | 172 | 9 | int:MAPRE3 | |
| Interaction | NUP50 interactions | BCL7B RFX1 TIPARP PPP1R3A YEATS2 ARID2 MARF1 KMT2A BOD1L1 KIF18B SAP130 | 1.73e-04 | 341 | 172 | 11 | int:NUP50 |
| Interaction | LHX2 interactions | 1.80e-04 | 183 | 172 | 8 | int:LHX2 | |
| Interaction | KLF15 interactions | HIVEP1 EP400 POGZ KMT2C ARID2 ZNF644 NFRKB SEC16A SAP130 ZHX1 | 2.01e-04 | 290 | 172 | 10 | int:KLF15 |
| Interaction | APEX1 interactions | HIVEP1 EP400 CHAF1A SPTBN1 ZNF280C DAXX POGZ GSK3B DNTTIP2 JUN SCML2 BRD2 BRCA1 RNPEP TM2D2 ARID2 CBFA2T2 ZNF644 TLN1 KMT2A ATM KIF18B EIF4G3 S100PBP | 2.09e-04 | 1271 | 172 | 24 | int:APEX1 |
| Interaction | SUDS3 interactions | 2.11e-04 | 141 | 172 | 7 | int:SUDS3 | |
| Interaction | PCDHB4 interactions | 2.16e-04 | 3 | 172 | 2 | int:PCDHB4 | |
| Interaction | FBXO22 interactions | SPTBN1 PCDHB6 KMT2C ARID2 KIF19 KMT2A COBL RBM46 ATM GALNT5 PUM1 MUC4 SH3RF3 ARHGAP21 | 2.29e-04 | 540 | 172 | 14 | int:FBXO22 |
| Interaction | WWTR1 interactions | EP400 MPDZ CHD8 POGZ YEATS2 ABLIM1 SCML2 ANAPC1 ARID2 TLN1 SEC16A KMT2A | 2.82e-04 | 422 | 172 | 12 | int:WWTR1 |
| Interaction | GCM1 interactions | 2.88e-04 | 68 | 172 | 5 | int:GCM1 | |
| Interaction | BAG2 interactions | ACO2 UBN2 RFX1 BRWD3 TIPARP YEATS2 MRTFB BRD2 TLN1 NFRKB DNAJC5 BOD1L1 EIF4G3 PUM1 ARHGAP21 | 2.97e-04 | 622 | 172 | 15 | int:BAG2 |
| Interaction | GATA2 interactions | 3.18e-04 | 199 | 172 | 8 | int:GATA2 | |
| Interaction | MKNK1 interactions | 3.30e-04 | 70 | 172 | 5 | int:MKNK1 | |
| Interaction | RBBP7 interactions | TET2 RBM11 HIVEP1 EP400 CHAF1A DAXX UBN2 TIPARP BCL11B BRCA1 KMT2A SAP130 ZHX1 | 4.26e-04 | 507 | 172 | 13 | int:RBBP7 |
| Interaction | SMG7 interactions | RBM11 HIVEP1 CHD8 MLLT10 MORC4 GSK3B YEATS2 BRCA1 SEC16A PUM1 | 4.29e-04 | 319 | 172 | 10 | int:SMG7 |
| Interaction | FBLN5 interactions | 4.39e-04 | 159 | 172 | 7 | int:FBLN5 | |
| Interaction | SOX2 interactions | TET2 HIVEP1 EP400 SPTBN1 BCL7B CHD8 POGZ UBN2 RFX1 GSK3B TIPARP KMT2C JUN ANAPC1 ARID2 ZNF644 IGHM ZMIZ2 SEC16A MARF1 KMT2A BOD1L1 EIF4G3 SAP130 ARHGAP21 | 4.48e-04 | 1422 | 172 | 25 | int:SOX2 |
| Interaction | SETD1B interactions | 4.55e-04 | 75 | 172 | 5 | int:SETD1B | |
| Interaction | USP37 interactions | 4.62e-04 | 115 | 172 | 6 | int:USP37 | |
| Interaction | CTNND1 interactions | 4.68e-04 | 265 | 172 | 9 | int:CTNND1 | |
| Interaction | ZBTB21 interactions | 4.73e-04 | 161 | 172 | 7 | int:ZBTB21 | |
| Interaction | MYBL2 interactions | 4.91e-04 | 162 | 172 | 7 | int:MYBL2 | |
| Interaction | BRD9 interactions | 5.07e-04 | 117 | 172 | 6 | int:BRD9 | |
| Interaction | NSD3 interactions | 5.07e-04 | 117 | 172 | 6 | int:NSD3 | |
| Interaction | ZYX interactions | ARHGAP32 HIPK2 ALS2 TIPARP ABLIM1 SEC16A COBL SSH2 ZHX1 ARHGAP21 | 5.45e-04 | 329 | 172 | 10 | int:ZYX |
| Interaction | ZMYM2 interactions | 5.50e-04 | 271 | 172 | 9 | int:ZMYM2 | |
| Interaction | FHL2 interactions | EP400 HIPK2 POGZ MORC4 RFX1 YEATS2 ABLIM1 MRTFB BRCA1 ASXL2 SAP130 | 6.15e-04 | 396 | 172 | 11 | int:FHL2 |
| Interaction | DCLRE1A interactions | 6.26e-04 | 20 | 172 | 3 | int:DCLRE1A | |
| Interaction | CASK interactions | 6.38e-04 | 221 | 172 | 8 | int:CASK | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q23 | 2.45e-05 | 220 | 176 | 7 | chr11q23 | |
| Cytoband | 11q23.3 | 2.39e-04 | 78 | 176 | 4 | 11q23.3 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 8.93e-06 | 46 | 111 | 5 | 622 | |
| GeneFamily | Zinc fingers CXXC-type | 4.76e-05 | 12 | 111 | 3 | 136 | |
| GeneFamily | CD molecules|Mucins | 2.76e-04 | 21 | 111 | 3 | 648 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 3.69e-04 | 5 | 111 | 2 | 1199 | |
| GeneFamily | Sterile alpha motif domain containing | 2.11e-03 | 88 | 111 | 4 | 760 | |
| GeneFamily | Laminin subunits | 2.37e-03 | 12 | 111 | 2 | 626 | |
| GeneFamily | PDZ domain containing | 2.47e-03 | 152 | 111 | 5 | 1220 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.58e-03 | 50 | 111 | 3 | 721 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 4.22e-03 | 53 | 111 | 3 | 103 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.19e-03 | 181 | 111 | 5 | 694 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.36e-03 | 18 | 111 | 2 | 91 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | CRTC3 HIVEP1 EP400 KALRN SPTBN1 GAL3ST4 ABLIM1 KMT2A ATM SSH2 TET3 | 6.28e-08 | 189 | 175 | 11 | M3112 |
| Coexpression | GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP | PCSK5 CRTC3 RBM11 HIVEP1 SPTBN1 HIPK2 GAL3ST4 ABLIM1 SCML2 ATM TET3 | 1.01e-07 | 198 | 175 | 11 | M3104 |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP | 8.14e-07 | 195 | 175 | 10 | M7397 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.63e-05 | 177 | 175 | 8 | M39245 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.96e-05 | 180 | 175 | 8 | M8239 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | ARHGAP32 SZT2 KIF1B RUNX3 HINFP JUN ANKRD13C NFRKB SCP2 KMT2A BOD1L1 AVPI1 ATM EIF4G3 PUM1 CEP57 S100PBP | 3.10e-05 | 807 | 175 | 17 | M14594 |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 5.04e-05 | 194 | 175 | 8 | M7313 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | AFF2 VSTM2A PCDHB4 ANKS1B KIAA1549 GRIK1 GRIK2 CSMD2 UBN2 PLPPR1 BCL11B NALF1 KIAA1549L TULP4 SCN1A PCDH11X BOD1L1 ANKRD12 SSH2 RIMS2 | 5.28e-05 | 1106 | 175 | 20 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | CACNA1B CFAP276 AFF2 VSTM2A GRIK2 ABLIM1 NALF1 PTPRM SLC18A2 PCDH11X DNAJC5 RIMS2 | 5.34e-05 | 450 | 175 | 12 | M39072 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | PCSK5 KIF1B SPTBN1 VSTM2A HTRA3 CHD8 GRIK1 DCN GSK3B TIPARP ZCCHC14 KMT2C SCML2 BRD2 RTL3 PKHD1 AGFG2 RBM46 LTBP2 ANKRD12 PUM1 CEP57 UTRN | 1.36e-07 | 799 | 172 | 23 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | NEXMIF KIF1B SPTBN1 CHD8 GSK3B TIPARP KMT2C ABLIM1 SCML2 TC2N BRD2 TULP4 SLC18A2 SYCP1 RBM46 N4BP1 ASXL2 ANKRD12 PUM1 CEP57 UTRN CCDC158 | 3.54e-07 | 778 | 172 | 22 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | PCSK5 KIF1B SPTBN1 VSTM2A CHD8 GRIK1 DCN GSK3B TIPARP KMT2C SCML2 BRD2 TULP4 RTL3 TLN1 CXXC4 PCDH11X RBM46 ANKRD12 PUM1 CEP57 UTRN | 4.58e-07 | 790 | 172 | 22 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | PCSK5 KIF1B SPTBN1 VSTM2A CHD8 GRIK1 DCN GSK3B TIPARP ZCCHC14 KMT2C SCML2 BRD2 TULP4 PCDH11X PKHD1 RBM46 ANKRD12 GALNT5 PUM1 CEP57 UTRN | 5.78e-07 | 801 | 172 | 22 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | SPTBN1 VSTM2A CHD8 GRIK1 DCN GSK3B TIPARP SCML2 PCDH11X RBM46 GALNT5 PUM1 CEP57 UTRN | 7.25e-06 | 413 | 172 | 14 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 1.33e-05 | 175 | 172 | 9 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.71e-05 | 138 | 172 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | NEXMIF SPTBN1 CHD8 GSK3B TIPARP KMT2C ABLIM1 SCML2 SLC18A2 SYCP1 RBM46 ANKRD12 PUM1 | 1.71e-05 | 387 | 172 | 13 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | NEXMIF KIF1B SPTBN1 CHD8 GSK3B TIPARP KMT2C SCML2 TC2N BRCA1 SYCP1 RBM46 ASXL2 ANKRD12 ATM PUM1 CEP57 UTRN CCDC158 | 1.83e-05 | 776 | 172 | 19 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#2 | 2.09e-05 | 103 | 172 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | SPTBN1 VSTM2A CHD8 DCN GSK3B TIPARP SCML2 PKHD1 RBM46 LTBP2 PUM1 CEP57 UTRN | 2.68e-05 | 404 | 172 | 13 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_200 | 2.83e-05 | 148 | 172 | 8 | gudmap_developingGonad_e14.5_ ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | NEXMIF KIF1B SPTBN1 CHD8 GRIK1 BRWD3 GSK3B TIPARP SCML2 SLC18A2 PCDH11X AGFG2 RBM46 N4BP1 ASXL2 ANKRD12 PUM1 CEP57 UTRN | 2.97e-05 | 804 | 172 | 19 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_500 | 4.41e-05 | 79 | 172 | 6 | gudmap_developingGonad_P2_ovary_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | AFF2 KIF1B VSTM2A HIPK2 GAL3ST4 CHD8 NCKAP5 GRIK2 RUNX3 TIPARP ZIC1 BCL11B OTX2 KIAA1549L BRCA1 ZIC5 CXXC4 PCDH11X ATM RIMS2 SH3RF3 | 5.06e-05 | 986 | 172 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | NEXMIF SPTBN1 CHD8 GSK3B TIPARP ABLIM1 SCML2 TULP4 SLC18A2 SYCP1 RBM46 ANKRD12 | 6.42e-05 | 379 | 172 | 12 | gudmap_developingGonad_P2_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.00e-05 | 127 | 172 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | KIF1B CHD8 GSK3B TIPARP KMT2C TULP4 PCDH11X ANKRD12 CEP57 UTRN | 8.56e-05 | 275 | 172 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | ZXDC TET2 VSTM2A LAMB2 MFSD4A CHD8 NCKAP5 RUNX3 ZIC1 KMT2C OTX2 KIAA1549L TULP4 ZIC5 PTPRZ1 NFRKB PCDH11X | 9.51e-05 | 730 | 172 | 17 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | PCSK5 NEXMIF KIF1B SPTBN1 CHD8 GSK3B TIPARP ZCCHC14 SCML2 BRD2 BRCA1 AGFG2 RBM46 N4BP1 KIF18B PUM1 CEP57 UTRN | 9.99e-05 | 806 | 172 | 18 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500 | 1.12e-04 | 134 | 172 | 7 | gudmap_developingGonad_e18.5_ovary_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | SPTBN1 VSTM2A CHD8 GRIK1 DCN GSK3B TIPARP SCML2 PCDH11X RBM46 PUM1 UTRN | 1.23e-04 | 406 | 172 | 12 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.39e-04 | 97 | 172 | 6 | gudmap_developingGonad_e18.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | NEXMIF SPTBN1 CHD8 DCN GSK3B TIPARP KMT2C ABLIM1 SCML2 TULP4 SLC18A2 SYCP1 MARF1 RBM46 ANKRD12 PUM1 CEP57 | 1.80e-04 | 770 | 172 | 17 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.03e-04 | 196 | 172 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_100 | 2.60e-04 | 70 | 172 | 5 | gudmap_developingGonad_e14.5_ ovary_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | PCSK5 SPTBN1 VSTM2A HTRA3 CHD8 DCN GSK3B TIPARP ABLIM1 SCML2 BRD2 PKHD1 RBM46 LTBP2 PUM1 CEP57 UTRN | 2.69e-04 | 797 | 172 | 17 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_200 | 2.76e-04 | 155 | 172 | 7 | gudmap_developingGonad_e16.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_100 | 2.97e-04 | 72 | 172 | 5 | gudmap_developingGonad_e18.5_ovary_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | ZXDC TET2 VSTM2A LAMB2 GRIK2 RUNX3 ZIC1 BCL11B OTX2 CSF1 TULP4 PCDH11X | 2.98e-04 | 447 | 172 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.37e-04 | 74 | 172 | 5 | gudmap_developingGonad_e14.5_ testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | CCDC91 ARHGAP32 NEXMIF HIPK2 HTRA3 CHD8 GSK3B DNTTIP2 TIPARP ZCCHC14 SCML2 BRD2 BRCA1 IGHM SYCP1 RBM46 PUM1 | 3.84e-04 | 822 | 172 | 17 | gudmap_developingGonad_e14.5_ testes_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | SPTBN1 VSTM2A CHD8 DCN GSK3B TIPARP SCML2 PKHD1 LTBP2 PUM1 CEP57 | 3.91e-04 | 395 | 172 | 11 | gudmap_developingGonad_P2_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_500 | 4.06e-04 | 77 | 172 | 5 | gudmap_developingGonad_e18.5_epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.48e-04 | 168 | 172 | 7 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_200 | 4.60e-04 | 19 | 172 | 3 | gudmap_developingGonad_e16.5_epididymis_200_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_100 | 4.60e-04 | 19 | 172 | 3 | gudmap_developingGonad_e18.5_ovary_100_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.60e-04 | 339 | 172 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | PCSK5 KIF1B CHD8 GSK3B TIPARP SCML2 BRD2 RBM46 PUM1 CEP57 UTRN | 4.63e-04 | 403 | 172 | 11 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500 | 4.78e-04 | 45 | 172 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | CACNA1B FAT4 HIPK2 KIAA1549 GAL3ST4 RUNX3 GSK3B ZCCHC14 BCL11B PTPRZ1 ASXL2 GALNT5 ATL2 RIMS2 UTRN TBX5 | 5.36e-04 | 769 | 172 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_100 | 5.43e-04 | 82 | 172 | 5 | gudmap_developingGonad_P2_epididymis_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500 | AFF2 KIF1B NCKAP5 GRIK2 ZIC1 JUN BCL11B OTX2 MRTFB PTPRZ1 CXXC4 RIMS2 | 5.83e-04 | 482 | 172 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.90e-04 | 350 | 172 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.90e-04 | 230 | 172 | 8 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.61e-04 | 234 | 172 | 8 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | AFF2 HIPK2 GAL3ST4 GRIK2 RUNX3 ZIC1 OTX2 KIAA1549L ZIC5 CXXC4 PCDH11X RIMS2 | 7.48e-04 | 496 | 172 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | EPHB6 TET2 FAT4 CRTC3 AFF2 SZT2 NXPE4 NEXMIF ANKS1B KIAA1549 HTRA3 GRIK1 MON1B MORC4 CDKL5 CSF1 KIAA1549L PTPRZ1 IGHM SEC16A ANKRD12 | 7.93e-04 | 1208 | 172 | 21 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.30e-04 | 90 | 172 | 5 | gudmap_developingGonad_P2_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#5_top-relative-expression-ranked_1000 | CACNA1B LAMA1 GRIK1 GRIK2 BCL11B KIAA1549L PTPRZ1 SSH2 RIMS2 | 9.02e-04 | 306 | 172 | 9 | gudmap_developingKidney_e11.5_ureteric bud_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#4 | 9.17e-04 | 92 | 172 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | FAT4 DCN BRWD3 GSK3B ZCCHC14 SCML2 TULP4 ANAPC1 PCDH11X COBL RBM46 ASXL2 ATL2 UTRN TBX5 S100PBP | 9.43e-04 | 811 | 172 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | 9.63e-04 | 248 | 172 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | KIF1B VSTM2A HIPK2 LAMB2 GAL3ST4 CHD8 NCKAP5 GRIK2 RUNX3 ZIC1 OTX2 KIAA1549L BRCA1 TULP4 PTPRZ1 CXXC4 RIMS2 | 9.67e-04 | 893 | 172 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | KIF1B SPTBN1 CHD8 BRWD3 GSK3B TIPARP ZIC1 SCML2 BRD2 SLC18A2 PTPRZ1 PCDH11X N4BP1 PUM1 CEP57 UTRN | 9.92e-04 | 815 | 172 | 16 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1B ARHGAP32 KALRN ANKS1B MRTFB GALNT17 NALF1 KIAA1549L SCN1A PCDH11X RIMS2 | 4.41e-10 | 198 | 176 | 11 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | PRUNE2 PCSK5 MCAM LAMB2 SHROOM4 MRTFB PTPRM SLC18A2 AVPI1 UTRN | 3.10e-09 | 182 | 176 | 10 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | PRUNE2 PCSK5 MCAM LAMB2 SHROOM4 MRTFB PTPRM SLC18A2 AVPI1 UTRN | 3.10e-09 | 182 | 176 | 10 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | BRWD3 FBXO38 ARID2 ZNF644 MARF1 BOD1L1 ASXL2 ANKRD12 SAP130 TET3 | 3.83e-09 | 186 | 176 | 10 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1B KALRN ANKS1B GRIK2 MRTFB GALNT17 NALF1 KIAA1549L SCN1A RIMS2 | 6.98e-09 | 198 | 176 | 10 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1B KALRN ANKS1B GRIK2 MRTFB GALNT17 NALF1 KIAA1549L SCN1A RIMS2 | 6.98e-09 | 198 | 176 | 10 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.68e-09 | 200 | 176 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | PPP1R15A DNTTIP2 KMT2C JUN TLN1 KMT2A BOD1L1 N4BP1 ANKRD12 UTRN | 7.68e-09 | 200 | 176 | 10 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.19e-08 | 179 | 176 | 9 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-08 | 180 | 176 | 9 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 5.06e-08 | 183 | 176 | 9 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1B KALRN ANKS1B GRIK2 MRTFB GALNT17 NALF1 KIAA1549L RIMS2 | 9.11e-08 | 196 | 176 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.52e-08 | 197 | 176 | 9 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1B KALRN GRIK2 MRTFB GALNT17 NALF1 KIAA1549L SCN1A RIMS2 | 9.94e-08 | 198 | 176 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | CACNA1B KALRN ANKS1B GRIK2 MRTFB GALNT17 NALF1 KIAA1549L RIMS2 | 1.08e-07 | 200 | 176 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-07 | 160 | 176 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-07 | 160 | 176 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 5.90e-07 | 179 | 176 | 8 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.90e-07 | 179 | 176 | 8 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.90e-07 | 179 | 176 | 8 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.27e-07 | 184 | 176 | 8 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 7.27e-07 | 184 | 176 | 8 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.58e-07 | 185 | 176 | 8 | 847257d232b9993cad50c814fd4ffeef52385295 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.89e-07 | 186 | 176 | 8 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.21e-07 | 187 | 176 | 8 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.21e-07 | 187 | 176 | 8 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | droplet-Fat-SCAT-30m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-07 | 189 | 176 | 8 | 8161910a19089f8cc5a3f1fda039f41a2488f04f | |
| ToppCell | droplet-Fat-SCAT|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-07 | 189 | 176 | 8 | 264c59de2adb8bee5bb57633d79d530a8829617b | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.26e-07 | 190 | 176 | 8 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 9.63e-07 | 191 | 176 | 8 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.00e-06 | 192 | 176 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-06 | 192 | 176 | 8 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-06 | 193 | 176 | 8 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.08e-06 | 194 | 176 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.13e-06 | 195 | 176 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-06 | 195 | 176 | 8 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.22e-06 | 197 | 176 | 8 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-06 | 197 | 176 | 8 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.22e-06 | 197 | 176 | 8 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.26e-06 | 198 | 176 | 8 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.26e-06 | 198 | 176 | 8 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.26e-06 | 198 | 176 | 8 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-06 | 198 | 176 | 8 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-06 | 198 | 176 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.36e-06 | 200 | 176 | 8 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.36e-06 | 200 | 176 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.36e-06 | 200 | 176 | 8 | a0cc84add181109bb66ba9d49c732e1790222c96 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.36e-06 | 200 | 176 | 8 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.36e-06 | 200 | 176 | 8 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.36e-06 | 200 | 176 | 8 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.36e-06 | 200 | 176 | 8 | c1797542541747b524c9c22c723d24c8d027d486 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.36e-06 | 200 | 176 | 8 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.36e-06 | 200 | 176 | 8 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.36e-06 | 200 | 176 | 8 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.36e-06 | 200 | 176 | 8 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 163 | 176 | 7 | 385b24e18df5ef92108483de312d6c85a1e6d145 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-06 | 163 | 176 | 7 | 8004cc0b3428be08b89957b563cd8799f822d931 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 165 | 176 | 7 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | wk_15-18-Epithelial-PNS-COL20A1+_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.81e-06 | 177 | 176 | 7 | b8cc6a7abf83a9844a5293b6cc4b19135b51fd53 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 178 | 176 | 7 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 178 | 176 | 7 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.33e-06 | 179 | 176 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 7.60e-06 | 180 | 176 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.60e-06 | 180 | 176 | 7 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.60e-06 | 180 | 176 | 7 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-06 | 181 | 176 | 7 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-06 | 181 | 176 | 7 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.88e-06 | 181 | 176 | 7 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-06 | 181 | 176 | 7 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.17e-06 | 182 | 176 | 7 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 182 | 176 | 7 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.17e-06 | 182 | 176 | 7 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 182 | 176 | 7 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.17e-06 | 182 | 176 | 7 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-06 | 183 | 176 | 7 | a253ad65673fce6cb453e709cb235ce7cbfa18b7 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-06 | 183 | 176 | 7 | ddc45fb591ba0ce3fa05c08051d58286a89ef835 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.47e-06 | 183 | 176 | 7 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.47e-06 | 183 | 176 | 7 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.47e-06 | 183 | 176 | 7 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 8.47e-06 | 183 | 176 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 184 | 176 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 8.77e-06 | 184 | 176 | 7 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 184 | 176 | 7 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 184 | 176 | 7 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | remission-CD8+_T_naive|World / disease stage, cell group and cell class | 9.09e-06 | 185 | 176 | 7 | 69304d7dd406ac7e96d51c239d7035a06d88704f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.09e-06 | 185 | 176 | 7 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.09e-06 | 185 | 176 | 7 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-06 | 186 | 176 | 7 | 5d0cd07b6b51e8ce9e1da949f757dc4575ec5752 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.75e-06 | 187 | 176 | 7 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.75e-06 | 187 | 176 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 188 | 176 | 7 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.04e-05 | 189 | 176 | 7 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-05 | 189 | 176 | 7 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 176 | 7 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 176 | 7 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 189 | 176 | 7 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-05 | 189 | 176 | 7 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-05 | 190 | 176 | 7 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-05 | 190 | 176 | 7 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.08e-05 | 190 | 176 | 7 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.20e-04 | 49 | 107 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Drug | 2,4,4'-trichlorobiphenyl | PRUNE2 HIVEP1 EP400 KALRN CHAF1A KIF1B ANKS1B KIF4A MFSD4A ALS2 ITGAD UBN2 PLPPR1 CEP164 BRWD3 PPP1R3A PASK ABLIM1 SCML2 GALNT17 SLC18A2 SCN1A PCDH11X MRGPRX2 AVPI1 N4BP1 ANKRD12 ATM KIF18B SH3RF3 S100PBP | 1.24e-07 | 1411 | 176 | 31 | ctd:C081766 |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | PRUNE2 HIVEP1 EP400 KALRN CHAF1A KIF1B ANKS1B KIF4A MFSD4A ALS2 ITGAD UBN2 PLPPR1 CEP164 BRWD3 PPP1R3A PASK ABLIM1 SCML2 GALNT17 SLC18A2 SCN1A PCDH11X MRGPRX2 AVPI1 N4BP1 ANKRD12 ATM KIF18B SH3RF3 S100PBP | 1.96e-07 | 1441 | 176 | 31 | ctd:C009828 |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | STARD13 EP400 HIPK2 MLLT10 CEP164 TULP4 BICRAL N4BP1 EIF4G3 S100PBP | 2.85e-06 | 194 | 176 | 10 | 4662_DN |
| Disease | Intellectual Disability | CACNA1B LAMA1 PEX6 KIF4A CHD8 POGZ BRWD3 SHROOM4 KMT2C BCL11B BRCA1 SCN1A PUM1 TET3 | 4.11e-07 | 447 | 172 | 14 | C3714756 |
| Disease | neuroimaging measurement | CCDC91 SZT2 CHAF1A KIF1B SPTBN1 NCKAP5 MLLT10 ABLIM1 BCL11B NALF1 BRCA1 CBFA2T2 FSHR SYCP1 PKHD1 SSH2 KIF18B CEP57 SH3RF3 | 1.67e-05 | 1069 | 172 | 19 | EFO_0004346 |
| Disease | red blood cell density measurement | STARD13 TET2 HIVEP1 EP400 KALRN ACO1 SPTBN1 VSTM2A BCL11B OTX2 ARID2 SYCP1 PKHD1 KIF4B SSH2 EIF4G3 MUC4 | 1.67e-05 | 880 | 172 | 17 | EFO_0007978 |
| Disease | Neurodevelopmental Disorders | 1.80e-05 | 93 | 172 | 6 | C1535926 | |
| Disease | Macrocephaly | 3.10e-05 | 11 | 172 | 3 | C0221355 | |
| Disease | Liver carcinoma | OLFML2B ACO2 KIF4A RUNX3 DCN KMT2C JUN ZIC5 ARID2 KMT2A ATM KIF18B | 4.59e-05 | 507 | 172 | 12 | C2239176 |
| Disease | body weight | CCDC91 PCSK5 CACNA1B TET2 HIVEP1 NEXMIF KIZ ZNF280C ANKS1B CHD8 GRIK2 MLLT10 MON1B GSK3B PPP1R3A BCL11B TULP4 RTL3 ZMIZ2 LTBP2 | 4.96e-05 | 1261 | 172 | 20 | EFO_0004338 |
| Disease | Leukemia, Myelocytic, Acute | 7.31e-05 | 173 | 172 | 7 | C0023467 | |
| Disease | hematocrit | STARD13 HIVEP1 KALRN ACO1 CHAF1A KIF1B PEX6 CEP164 BCL11B ARID2 ZMIZ2 PKHD1 AGFG2 ASXL2 SSH2 ARHGAP21 TBX5 | 9.35e-05 | 1011 | 172 | 17 | EFO_0004348 |
| Disease | polyunsaturated fatty acid measurement, sex interaction measurement | 2.01e-04 | 4 | 172 | 2 | EFO_0008343, EFO_0010733 | |
| Disease | Medulloblastoma | 2.08e-04 | 50 | 172 | 4 | C0025149 | |
| Disease | skin hydration measurement | 2.40e-04 | 21 | 172 | 3 | EFO_0009586 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.76e-04 | 152 | 172 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | glaucoma | 2.96e-04 | 154 | 172 | 6 | MONDO_0005041 | |
| Disease | Seizures | 3.04e-04 | 218 | 172 | 7 | C0036572 | |
| Disease | Jaw Abnormalities | 3.34e-04 | 5 | 172 | 2 | C0022360 | |
| Disease | ficolin-2 measurement | 3.34e-04 | 5 | 172 | 2 | EFO_0008135 | |
| Disease | SUN domain-containing protein 3 measurement | 3.34e-04 | 5 | 172 | 2 | EFO_0802102 | |
| Disease | colon adenocarcinoma (is_marker_for) | 4.07e-04 | 25 | 172 | 3 | DOID:234 (is_marker_for) | |
| Disease | biological sex | 4.20e-04 | 230 | 172 | 7 | PATO_0000047 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 5.08e-04 | 63 | 172 | 4 | DOID:0050866 (is_marker_for) | |
| Disease | neuroticism measurement, cognitive function measurement | TET2 HIVEP1 KALRN ANKS1B MLLT10 ZCCHC14 BCL11B ZMIZ2 CXXC4 EIF4G3 CEP57 | 5.15e-04 | 566 | 172 | 11 | EFO_0007660, EFO_0008354 |
| Disease | cholangiocarcinoma (is_marker_for) | 5.39e-04 | 64 | 172 | 4 | DOID:4947 (is_marker_for) | |
| Disease | Carcinoma, Granular Cell | 6.04e-04 | 116 | 172 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 6.04e-04 | 116 | 172 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 6.04e-04 | 116 | 172 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 6.04e-04 | 116 | 172 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 6.04e-04 | 116 | 172 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 6.04e-04 | 116 | 172 | 5 | C0001418 | |
| Disease | ovarian carcinoma | 6.20e-04 | 321 | 172 | 8 | EFO_0001075 | |
| Disease | Movement Disorders | 6.36e-04 | 29 | 172 | 3 | C0026650 | |
| Disease | Glycosuria | 6.96e-04 | 7 | 172 | 2 | HP_0003076 | |
| Disease | Schizophrenia | CACNA1B ARHGAP32 LAMA1 GRIK1 GRIK2 CSMD2 GSK3B JUN BRCA1 SLC18A2 PTPRZ1 KMT2A ATM RIMS2 | 7.02e-04 | 883 | 172 | 14 | C0036341 |
| Disease | congenital heart disease (implicated_via_orthology) | 7.17e-04 | 69 | 172 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | cortical thickness | CCDC91 CPAMD8 CHAF1A SPTBN1 LAMA1 NCKAP5 MLLT10 BCL11B NALF1 FSHR PKHD1 KMT2A SSH2 EIF4G3 SH3RF3 ARHGAP21 | 8.40e-04 | 1113 | 172 | 16 | EFO_0004840 |
| Disease | temporal horn of lateral ventricle volume measurement | 8.42e-04 | 72 | 172 | 4 | EFO_0010333 | |
| Disease | Acute Myeloid Leukemia, M1 | 8.47e-04 | 125 | 172 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 8.47e-04 | 125 | 172 | 5 | C1879321 | |
| Disease | cortical surface area measurement | CCDC91 TET2 CPAMD8 CHAF1A KIF1B SPTBN1 HIPK2 CRPPA GAL3ST4 NCKAP5 ZIC1 BCL11B NALF1 FSHR PKHD1 SSH2 SH3RF3 ARHGAP21 | 9.09e-04 | 1345 | 172 | 18 | EFO_0010736 |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 9.34e-04 | 74 | 172 | 4 | DOID:3748 (is_marker_for) | |
| Disease | Abnormality of the face | 1.18e-03 | 9 | 172 | 2 | C4025871 | |
| Disease | Glaucoma | 1.18e-03 | 9 | 172 | 2 | C0017601 | |
| Disease | Glioblastoma | 1.19e-03 | 79 | 172 | 4 | C0017636 | |
| Disease | Mitral valve prolapse | 1.21e-03 | 36 | 172 | 3 | HP_0001634 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.36e-03 | 139 | 172 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | neuroblastoma (is_implicated_in) | 1.47e-03 | 10 | 172 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Peripheral T-Cell Lymphoma | 1.47e-03 | 10 | 172 | 2 | C0079774 | |
| Disease | age at onset, multiple sclerosis | 1.47e-03 | 10 | 172 | 2 | EFO_0004847, MONDO_0005301 | |
| Disease | stomach cancer (is_marker_for) | 1.50e-03 | 142 | 172 | 5 | DOID:10534 (is_marker_for) | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 1.56e-03 | 85 | 172 | 4 | EFO_0000708, EFO_0006953 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.64e-03 | 145 | 172 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | colorectal cancer, hormone replacement therapy | 1.78e-03 | 88 | 172 | 4 | EFO_0003961, MONDO_0005575 | |
| Disease | ovary epithelial cancer (is_implicated_in) | 1.79e-03 | 11 | 172 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | cocaine use | 1.79e-03 | 11 | 172 | 2 | C3496069 | |
| Disease | Childhood Medulloblastoma | 2.02e-03 | 43 | 172 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 2.02e-03 | 43 | 172 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 2.02e-03 | 43 | 172 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 2.02e-03 | 43 | 172 | 3 | C0751291 | |
| Disease | childhood gender nonconformity | 2.02e-03 | 43 | 172 | 3 | EFO_0020103 | |
| Disease | Adult Medulloblastoma | 2.02e-03 | 43 | 172 | 3 | C0278876 | |
| Disease | chronotype measurement | RGSL1 HIVEP1 ACO2 PRAG1 OTX2 NALF1 ARID2 ZMIZ2 FSHR CXXC4 PKHD1 KIF18B EIF4G3 | 2.07e-03 | 882 | 172 | 13 | EFO_0008328 |
| Disease | Mitral valve prolapse, response to surgery | 2.15e-03 | 12 | 172 | 2 | EFO_0009951, HP_0001634 | |
| Disease | Mouth Diseases | 2.15e-03 | 12 | 172 | 2 | C0026636 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.31e-03 | 45 | 172 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.32e-03 | 157 | 172 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 2.53e-03 | 13 | 172 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | alcohol consumption measurement | ACO2 SPTBN1 BCL7B ANKS1B NCKAP5 ZIC1 BCL11B OTX2 NALF1 ARID2 CXXC4 PKHD1 COBL ASXL2 RIMS2 TET3 | 2.57e-03 | 1242 | 172 | 16 | EFO_0007878 |
| Disease | epilepsy (implicated_via_orthology) | 2.73e-03 | 163 | 172 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Pancreatic Neoplasm | 2.83e-03 | 100 | 172 | 4 | C0030297 | |
| Disease | memory performance | 2.86e-03 | 409 | 172 | 8 | EFO_0004874 | |
| Disease | Generalized seizures | 2.93e-03 | 101 | 172 | 4 | C0234533 | |
| Disease | Clonic Seizures | 2.93e-03 | 101 | 172 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 2.93e-03 | 101 | 172 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 2.93e-03 | 101 | 172 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 2.93e-03 | 101 | 172 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 2.93e-03 | 101 | 172 | 4 | C0751123 | |
| Disease | Complex partial seizures | 2.93e-03 | 101 | 172 | 4 | C0149958 | |
| Disease | Single Seizure | 2.93e-03 | 101 | 172 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 2.93e-03 | 101 | 172 | 4 | C3495874 | |
| Disease | Visual seizure | 2.93e-03 | 101 | 172 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 2.93e-03 | 101 | 172 | 4 | C0270846 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 2.93e-03 | 101 | 172 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Vertiginous seizure | 2.93e-03 | 101 | 172 | 4 | C0422855 | |
| Disease | Gustatory seizure | 2.93e-03 | 101 | 172 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 2.93e-03 | 101 | 172 | 4 | C0422850 | |
| Disease | Olfactory seizure | 2.93e-03 | 101 | 172 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 2.93e-03 | 101 | 172 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 2.93e-03 | 101 | 172 | 4 | C4505436 | |
| Disease | Jacksonian Seizure | 2.93e-03 | 101 | 172 | 4 | C0022333 | |
| Disease | Epileptic Seizures | 2.93e-03 | 101 | 172 | 4 | C4317109 | |
| Disease | Absence Seizures | 3.04e-03 | 102 | 172 | 4 | C4316903 | |
| Disease | Convulsions | 3.04e-03 | 102 | 172 | 4 | C4048158 | |
| Disease | Tonic Seizures | 3.04e-03 | 102 | 172 | 4 | C0270844 | |
| Disease | Malignant neoplasm of pancreas | 3.04e-03 | 102 | 172 | 4 | C0346647 | |
| Disease | intraocular pressure measurement | 3.11e-03 | 509 | 172 | 9 | EFO_0004695 | |
| Disease | QRS amplitude, QRS complex | 3.12e-03 | 50 | 172 | 3 | EFO_0005054, EFO_0007742 | |
| Disease | Seizures, Focal | 3.26e-03 | 104 | 172 | 4 | C0751495 | |
| Disease | Myoclonic Seizures | 3.26e-03 | 104 | 172 | 4 | C4317123 | |
| Disease | Tonic - clonic seizures | 3.26e-03 | 104 | 172 | 4 | C0494475 | |
| Disease | smoking status measurement | ANKS1B GRIK1 GRIK2 MLLT10 MON1B ZCCHC14 BCL11B GALNT17 CSF1 TULP4 PKHD1 BICRAL EIF4G3 UTRN TET3 | 3.36e-03 | 1160 | 172 | 15 | EFO_0006527 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TTDHISPAGNIARNS | 676 | P21399 | |
| SSGQHVDVSPTSQRL | 551 | Q99798 | |
| TSQASASAPRHQPAS | 1526 | Q96L91 | |
| PSSSVTGAHVAQIQA | 166 | Q9HCK8 | |
| ATSPVSLHLRTSFNS | 86 | Q9N2J8 | |
| PLHSAQAVDVASASN | 16 | Q9H4A4 | |
| NQLPSSITSSGHVAR | 651 | Q7Z408 | |
| TSQGSINSPVYSRHS | 451 | O14639 | |
| SQAENHASTALSPST | 266 | Q96Q42 | |
| RDSHNPSTVLASQAS | 161 | P51816 | |
| ALFGPSHSSSVSAVQ | 106 | P39086 | |
| NAPSGTTVIHLNATD | 3206 | Q6V0I7 | |
| TQTHVASAPASRAVV | 491 | Q68CP9 | |
| HNSSVTANSQSPALL | 81 | Q8N6S4 | |
| GSHLSNSFAEPSRSN | 11 | Q86XR8 | |
| HSALANPQSATETAS | 101 | Q5T686 | |
| DQNTSVSHARTSSPF | 1481 | Q6RI45 | |
| AAATLEQPASSSHAQ | 26 | P20800 | |
| QAASSHEQARSSPGE | 3286 | P20930 | |
| NVSNIHSSFATSPTG | 1361 | Q6UB98 | |
| GPTHVSTRNADIFNS | 521 | Q13111 | |
| QQSESLSPAHTSDFR | 116 | Q9BQE9 | |
| ANSSPIHFAGAQTSL | 2206 | Q00975 | |
| ARLQGTSSHSADTPE | 396 | Q9UER7 | |
| LNPTRATATVASVSH | 806 | Q76L83 | |
| SIQGSIVSPHTAATN | 141 | Q5T5A4 | |
| NSASVSSSLNHVPDL | 166 | P57052 | |
| FHRSSINSLSPVSAT | 471 | Q8TBY0 | |
| ENNSPALHIGSVSAT | 461 | Q9Y5E4 | |
| TLSGTVADSTPAHFQ | 146 | Q7Z3E1 | |
| HTASASLQSVAGTEP | 26 | A4D126 | |
| QVALTETAPGSQHSS | 91 | Q9HCM3 | |
| PATSTDQAAHNGLFT | 531 | Q7L1V2 | |
| TPQNVATSSSLTAHL | 291 | Q9H1A4 | |
| NASEVAVTTPGTSNH | 481 | Q7Z6G8 | |
| HPSINTAVANVGTTS | 6296 | Q8WXI7 | |
| SHGADVSSAIPTNIS | 10631 | Q8WXI7 | |
| ASLVTHPEAQTSSAI | 10766 | Q8WXI7 | |
| TALQAAPSSHDATLG | 711 | Q99102 | |
| AQTTAEPSRSFSSAH | 31 | Q96RG2 | |
| PRSQSDSFGTSQTAH | 2306 | Q8NEZ4 | |
| VHNQAPSSTSATISL | 591 | Q9H2X6 | |
| TAFSQVVASHRVATP | 126 | Q96JG8 | |
| SAPSAHLFDSSQLVS | 856 | Q8N9B5 | |
| SQTAPSSQAAARVVS | 781 | Q6P4R8 | |
| PANSTANTTSRGHLF | 171 | Q8N468 | |
| LHSQNTLPSVTSAAQ | 121 | P05412 | |
| LASENQRPGHFSTAS | 421 | O60333 | |
| QSRTSLQFHSPGIST | 1781 | Q5HYC2 | |
| QVPLRSHSSSSSSEE | 1221 | Q2LD37 | |
| LPVNITSAQESASSH | 126 | Q8IWD5 | |
| TELVSRQHSPGSADS | 401 | O43439 | |
| QRCTDNHTGTSASAP | 376 | Q92824 | |
| SISAVDNGSLANTPH | 256 | P07585 | |
| AQARESSNTSQPHLA | 226 | Q13608 | |
| VSGRPFNTQESSSLH | 391 | Q32MH5 | |
| ARDSAVSNNKTPHSS | 721 | O60229 | |
| PTGTSNATRVENVHS | 476 | Q9ULH7 | |
| SPVSNSASARHRTEA | 1356 | P55268 | |
| AAAHNTTRTAAPAST | 196 | Q9UQV4 | |
| SATANDSANPLHLSA | 141 | Q6ZVL6 | |
| TAAHSSSQEVLATVP | 181 | Q6ZUF6 | |
| HAFTPSSRQQDLVST | 726 | P23471 | |
| LNTTPAASSSDSALH | 781 | P23471 | |
| NAPVGTSVTQLHATD | 261 | Q9BZA7 | |
| ASATETTQLTADSHP | 176 | Q9H3Z4 | |
| PHSHRQTAQSSNVTD | 191 | Q2M2Z5 | |
| PTTADFAAATLQRTH | 1286 | A7KAX9 | |
| VTDHRSQISSPASFD | 266 | Q96RP7 | |
| TQHPTDANATSSRSH | 211 | Q86Y91 | |
| AANQALAAGTHSSPV | 51 | Q14671 | |
| AITADVSHSPRTNLS | 576 | Q16821 | |
| SGISPSHSQRIASSQ | 561 | Q13349 | |
| AHISPASSAFEESRN | 321 | Q2TAC6 | |
| ENNSPALHIGSVSAT | 461 | Q9Y5E5 | |
| RIPDSTHAQLESSSS | 761 | Q9UQ26 | |
| SSHNTASQSPDFVRT | 716 | Q6PIJ6 | |
| NIPSQSTRHSTVATE | 1236 | P38398 | |
| EPVLETASSSAHSTQ | 971 | Q8NFC6 | |
| SRSSTPVHNSEIQET | 126 | Q96QU4 | |
| HFSQTSRSTTPANLD | 1876 | Q13315 | |
| IITNAHVVSSNSAAP | 186 | P83110 | |
| DARQSPFATSSEHSS | 731 | Q9C0K0 | |
| QTFAASGSPVIANHA | 476 | Q6AI39 | |
| AQPQLSRSHSSGSVL | 421 | P09603 | |
| SHPNATFSAVGEASI | 276 | P01871 | |
| QSHDDLSNATATPSV | 661 | O14523 | |
| AIISSPENTHAANSI | 66 | Q7Z6B0 | |
| PETTLHSTRAQSQTQ | 456 | A2CJ06 | |
| AHQGFSRQLSSTSPL | 401 | Q6UUV7 | |
| SQAVANERAHPASTA | 231 | Q7Z7M9 | |
| GNLESSTQSASPFHR | 1821 | Q8IZJ3 | |
| ETAPRVTSFASNLHT | 626 | O75128 | |
| HARIQAAASTPTNAT | 381 | P49841 | |
| RRTSDPSAAVNHVSS | 21 | Q8NHH9 | |
| TALHSPAAASAAVTD | 86 | Q9H2H0 | |
| AEVANLSAHSASPIQ | 46 | Q6IS24 | |
| HPTATASSQLSSNAL | 301 | Q14767 | |
| SQARQSPLGSSQSHD | 941 | Q9Y4F3 | |
| SPETSRSSDAFTTQH | 501 | O95239 | |
| SPETSRSSDAFTTQH | 501 | Q2VIQ3 | |
| ENRTIAHSPTSFTES | 2091 | Q03164 | |
| PASVTRSHSNVPSSQ | 866 | Q5M9N0 | |
| TETSSTVHNTHPRNG | 656 | P23945 | |
| IFGPSHSSSANAVQS | 106 | Q13002 | |
| TALSASQDNPSSVIH | 451 | Q9BQA5 | |
| SFHENNVSTRVSSLP | 726 | O76039 | |
| SSASNHPASSDPRFQ | 846 | O76039 | |
| SENPTSVFSRISDHS | 231 | Q96BU1 | |
| SAHLAASTPVTAASD | 201 | O43432 | |
| SSTAHQLDAAAPTVS | 836 | Q8TDX9 | |
| QAVATPSRSSAAAAA | 651 | O75807 | |
| SSHSQDSAQVTSLIP | 336 | Q3SYA9 | |
| TSATHSTATILNPRD | 96 | Q8N323 | |
| THNLNGRSVSSPSSF | 811 | P28827 | |
| SSHSRDSAQVTSLIP | 566 | A6NNC1 | |
| NNSPALHIGSVSATD | 461 | Q9Y5E3 | |
| PAQTRVSSSSSHQEA | 56 | Q6ZRI0 | |
| AVTSHLNQSPASLST | 226 | P32243 | |
| TSTPVSHTLVANSEA | 986 | Q685J3 | |
| TSTPVSHTLVANSEA | 1811 | Q685J3 | |
| TASPHTRANSTSTER | 536 | P43121 | |
| RGSLSTTSHFSSQPQ | 216 | Q13761 | |
| ASSIQDELSHTSPAT | 366 | Q8N8U3 | |
| LQPSGSDSSHAQFAA | 546 | Q5T011 | |
| TASDPQHHRSTSESS | 1631 | Q5T011 | |
| SSHQPSFAALNRTGD | 2026 | P46939 | |
| ENFTTAHNTSGRSAP | 831 | A5PLK6 | |
| ASPHISSQTASQLSL | 601 | Q9Y3M8 | |
| TLLHSSTNSRQTAPD | 1096 | Q8WUY3 | |
| IQRHDSLSSVPSSSS | 186 | Q8N9U0 | |
| STVRQKVASNHSPFS | 261 | Q99593 | |
| STDGQRPADSAIVHS | 1776 | O14513 | |
| SATHSTATILNPRDT | 96 | Q6UWF7 | |
| QSYSHTTRASPATVQ | 426 | P22670 | |
| APEHAANSASVNAIS | 86 | Q5QGS0 | |
| NAVGAESPHTQSTSV | 2996 | P25391 | |
| PVVVSNNSSAHGSQR | 336 | Q7Z3K3 | |
| AAAINVSTSHEVPSA | 476 | O15197 | |
| QSNSSSHTRPFSAIA | 41 | Q8TE76 | |
| RAFSESHISLAPQST | 1056 | Q9ULL8 | |
| PHSANLTSTDRAPSN | 3221 | P08F94 | |
| HPVSVVLSSLNSSAN | 261 | Q96LB1 | |
| HSTAVTSDLNARTAP | 356 | Q68BL8 | |
| ANHASVGPTLQTTSV | 386 | Q68BL8 | |
| ESPLETLSAQNHSAS | 306 | Q8TBJ4 | |
| ASSFRTHQIEAVPTS | 411 | P22307 | |
| TAQHLAAVQSSGAPA | 151 | Q9H6W3 | |
| AATATASEHSREPSA | 461 | P35498 | |
| HEVSASTQSTPASSR | 2311 | Q01082 | |
| QGSVTSAHQVPAVSS | 206 | P25440 | |
| SAHQVPAVSSVSHTA | 211 | P25440 | |
| ATTNPFLTIHGDNAS | 1036 | P55197 | |
| PVSQSHARTSQARST | 196 | O95081 | |
| SDNQSVHSSSEPLRN | 226 | Q9UPV0 | |
| LSSATAAQNIPSSVH | 46 | Q8N326 | |
| IQAHPESSTGSDART | 31 | Q5QJE6 | |
| ASLAHTASASPLASQ | 1051 | Q9NRJ4 | |
| SRSHSQNATAEPELT | 31 | Q9BX73 | |
| ALVAQGSHSSTNSPV | 1096 | Q6ZU65 | |
| VSAAIPSSIHGSANQ | 176 | Q8TAG5 | |
| ALTSNSNLAAHITTP | 626 | Q2QGD7 | |
| SVVTGHQQEPASSSL | 1951 | O75970 | |
| HQQEPASSSLSFTGL | 1956 | O75970 | |
| PSHSDSLASQQSVAS | 1011 | O15027 | |
| ADDQRSSSLSNTPHA | 701 | Q76I76 | |
| HTSVSQDFSRSVPGT | 566 | Q9UQR0 | |
| AHSAAQAQDRPTATV | 611 | Q8TEJ3 | |
| PSQTVSRNFTSVDHG | 816 | Q15431 | |
| TIAAAQHAASTPKAS | 931 | Q9Y490 | |
| TRAQSPVITTTAAHA | 296 | Q9H0E3 | |
| ESNTSTSIVNRIHPS | 231 | Q9UKY1 | |
| HSVSRDPSPFAQSSN | 1376 | O43151 | |
| PHQTASDFVRDSAAS | 1096 | Q86YV5 | |
| HAARPSTDFTQAAAA | 136 | Q8NF64 | |
| QSSLFIHAGAPTVSS | 91 | Q9H582 | |
| PVSSVSNSLENALHT | 61 | Q8WYQ9 | |
| PSSHELASAGQTAFT | 51 | Q15915 | |
| HVLPSTSSSDNSVQL | 726 | Q86YA3 | |
| PAISNILNRGHSSSS | 56 | Q8ND82 | |
| ATTSRSDQLTPQGHV | 26 | Q9BWQ6 | |
| QTARPVHTASISDSF | 61 | Q05940 | |
| SRSQAVEAPSVSVNH | 361 | Q5T5U3 | |
| HIPASAVISASTSQV | 821 | Q5T5U3 | |
| TRQTTAAELDSHTPA | 1066 | Q6N021 | |
| HRNTVTEVSGTTNPA | 2441 | P15822 | |
| LSSSHPRSRSAAAQS | 651 | A8MT70 | |
| ANQRAETPSANHSES | 126 | Q9ULM3 | |
| ARSHSSTLSPQVTNL | 606 | Q96T25 | |
| AAQAHRLLSASSSPT | 116 | B1AL88 | |
| SFRVPGTQAASTSHQ | 796 | O75113 |